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ABSTRACT
The first part of the work is dedicated to the selective detection of Homocysteine (Hcy). In
order to better understand this colorimetric detection method, a thermodynamic model for the pH
dependence of the effective reduction potential of Hcy derived α-carbon radicals has been
proposed. And using viologen indicators of varying reduction potentials, we demonstrate that
colorimetric changes occur at experimental pH values consistent with the model.
The one-carbon bridge stereochemistry of bicyclo[3.3.1]nonane framework is critical to
make the third ring of the tricyclic precursor of vinigrol. We studied this stereochemistry
carefully and found that the major diastereomer formed from Robinson annulations places the
one-carbon bridge substituent anti to the β-keto ester/amide unit introduced in the reaction and
stereoselectivity appears to be kinetically controlled. The origin of this diastereoselection has
been identified by density functional theory calculations.
Efforts toward the total synthesis of vinigrol have been described. The tricyclic precursor of
vinigrol has been efficiently synthesized in gram scale utilizing the Robinson annulation, base
catalyzed epimerization and intramolecular alkylation as the pivotal steps. The thermal [2+2]
reaction with dichloroketene remains in vain although several different approaches have been
explored. Finally, an alternative route using the tricyclic enone as the electrocyclic reaction
precursor has been investigated. This enone can be obtained from the tricyclic precursor via
either a selenation- or a bromination-elimination sequence. Further transformation involving
olefination, electrocyclic reaction and oxidative cleavage to generate the bridging eightmembered ring, would complete the synthesis of the vinigrol core.

xi

CHAPTER 1 UNDERSTANDING THE SELECTIVE DETECTION OF
HOMOCYSTEINE
1.1 Background and Significance
Homocysteine (Hcy) is an accepted independent risk factor for several major pathologies
including cardiovascular disease, birth defects, osteoporosis, Alzheimer’s disease, and renal
failure.[1] Elevated levels of both Hcy and cysteine (Cys) have been associated with
neurotoxicity. In the case of Cys, this has been demonstrated in vivo in animals with immature
blood-brain barriers and in cultured neurons in vitro.[2] Additionally, Cys induced hypoglycemic
brain damage has been studied as an alternative mechanism to excitotoxicity.[3]
The role of Hcy in disease is unclear. After many years of study and impressive progress, it
is still not yet known if Hcy causes disease, is a consequence of it, or is simply a biomarker.[4]
There is an ongoing effort in the biomedical community involving the study of
hyperhomocysteinemia.[4]
Because Hcy is associated with a wide range of diseases,[5] there has been great interest in
the development of selective detection methods for it. Interference from structurally related
biological thiols such as Cys and GSH, typically present in much higher concentration, hinders
selective detection methods. Unlike Hcy, the relatively more common biological thiols, such as
GSH, are typically associated with beneficial antioxidant activity. It is thus also important to
understand the differences between the fundamental chemistry of Hcy and other biothiols.
1.2 Current State-of-the-Art in Selective Detection Methods of Hcy
Thiyl radicals, which can be produced from biological thiols,[6] have attracted a lot of
attention due to their important biological redox processes. The two major and interesting species
can be formed by thiyl radicals are α-amino carbon centered radicals and disulfide radical anions
(Scheme 1.1).


Portions of this chapter are printed by permission of Chemical Communications.
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Scheme 1.1 Interconversion between Thiyl Radicals, Carbon Radicals and Disulfide
Radical Anions
The formation of carbon radicals is not favored unless thiyl radicals could abstract
hydrogen atoms from suitably activated C-H groups, for example, from alcohols and ethers,[7] or
from the α carbon of amino acids.[8]

Scheme 1.2 Proton Abstraction Leading to Formation of the α-Aminoalkyl Radical
Oxidizing thiyl radicals formed from biological thiols interconvert with reducing, α-amino
carbon centered radicals under physiological, aerobic conditions (Scheme 1.1). The rate constant
for the thiyl radical interconverting with the carbon radical derived from Hcy has been detected
at pH 10.5 by Zhao et al.[9]
2

Strongin et al. recently reported a colorimetric detection method based on the selective
reduction of colorless methyl viologen (MV2+) to its blue radical cation (MV+•) by Hcy at neutral
pH (Scheme 1.2).[10] The selectivity of this detection method for Hcy was proposed to arise from
an intramolecular hydrogen atom abstraction converting the oxidizing Hcy thiyl radical to the
reducing Hcy α-amino carbon-centered radical through a kinetically favorable, five-membered
ring transition state (Scheme 1.2). In contrast, in the cases of Cys and GSH, H-atom abstraction
to afford a reducing carbon-centered radical would proceed via less-favored four- and ninemembered ring transition-state geometries, respectively (Scheme 1.2).

Scheme 1.3 Dealkylation of Alkyl Viologens under Basic Conditions
Earlier work by Zhao had shown that at pH 10.5 colorimetric detection of GSH, Cys and
Hcy was observed with no discernable selectivity.[9] Interconversion of thiyl radicals with
reducing disulfide radical anions (Scheme 1.1, eqn (2)) becomes more prominent with increasing
pH, and it is possible that at pH 10.5 nonselective MV2+ reduction results from the equally facile
formation of disulfide radical anions from all three biological thiols. Another possibility is the
well-known dealkylation process of methyl viologen itself (Scheme 1.3).[11] Because the
methanol resulting from the dealkylation can be a reducing agent, solutions of methyl viologen
under basic conditions can spontaneously be reduced and will then turn blue as the radical cation
is formed.
Conducting the viologen-mediated colorimetric assay at neutral pH has the advantage of
minimizing interference from nonselective MV2+ reduction by disulfide radical anions. However,
captodative stabilization of α-amino carbon-centered radicals requires lone pair donation from
nitrogen, and at neutral pH only a small fraction of the amino groups are not protonated. This
3

begs the question whether the reducing species producing the colorimetric response in the MV2+
assay could really be α-carbon radicals. To address this question we proposed a thermodynamic
model for the pH dependence of the effective reduction potential of Hcy derived α-carbon
radicals and, using viologen indicators of varying reduction potentials, tested whether
colorimetric changes occur at experimental pH values consistent with this model.
1.3 Proposed Thermodynamic Model
The ability of the carbon radicals to reduce a given substrate (e.g., methyl viologen) has
pH-dependence which is determined by Scheme 1.4.
NH3+
–

O2C

H
HR+S•

K1

NH2
–

O2C

S

H
RS•

S

+ H+

K1K2 =

K2
NH3+
–

O2C
HR+C•

SH

K3

[RC•][H+]
[HR+S•]

NH2
–

O2C

RC•

S
H

+ H+
K3 =

[RC•][H+]
[HR+C•]

+ e- - eNH2+
–

O2C

RC+

S
H

+ H+

Scheme 1.4 The Equilibrium Between Thiyl Radicals and Carbon Radicals
The mid-point potential Em(RC+/ RC•) at a given pH determines whether the α-carbon
radical will be able to reduce a particular substrate. The following relationship between Em(RC+/
RC•) and [H+] was derived from the Nernst equation:[12]
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Where Eo(RC+/ RC•) is the standard potential, which is also the minimum value possible
for Em(RC+/ RC•), and the pseudo-equilibrium constant, Kobs, is given by:

When [H+] >> Kobs (low pH), Em varies linearly with pH:

At 298K, RTln10/F = 59.2 mV. Since pH = -log[H+] and we can define pKobs = -logKobs,
the above equation can be re-written as:

When [H+] << Kobs (high pH), the pH-dependant part of the function goes to zero and Em
becomes constant, which is also the minimum value of Em:

To test this model, the effect of pH on the aminothiol-mediated reduction of a series of
viologen indicators was determined. This was accomplished by gently refluxing a buffered,
aqueous solution of the aminothiol (Hcy or Cys, 17 mM) and viologen (4.0 mM). In order to
study the reduction potential of α-carbon radicals derived from Hcy in the whole pH range, a
number of viologens with different reduction potentials were chosen.
1.4 Preparation of the Viologens

Scheme 1.5 Preparation of Viologens
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While viologens in entries 1, 4, 5, 7 and 8 in Table 1.1 are commercially available, the
other ones were prepared by nucleophilic alkylation of 4,4’-bipyridine as described in the
literature (Scheme 1.5).[13] Dimethoxy viologen was prepared by alkylation of N-Oxide
according to a known process (Scheme 1.5).[14]
1.5 Effect of pH on the Reduction Potentials of α-Carbon Radicals
Typically, color formation was observed (e.g., colorless to blue for MV2+) above a
certain pH. As the pH was increased, faster onset of color formation and deeper color change
were observed as well as longer persistence of color after the sample was removed from heating.
For most viologens (entries 3-8, Table 1.1) there was a pH range where color formation is
observed for Hcy but not Cys (selective Hcy detection). Hcy should have a stronger reduction
potential because of the particularly favorable formation of α-carbon radicals.
As solution pH decreases, we predict that Em(RC+/ RC•) should increase until Em(RC+/
RC•) > E0 (viologen) at which point no color formation could be observed. Upon lowering the pH
we observed slower onset of color formation and less intense color change as well as shorter
persistence of color after the sample is removed from heating. For six of the eight viologens
examined we were able to obtain a pH endpoint (minimum pH where color formation was
observable) below which no color formation occurred. As predicted, lower pH endpoints were
observed for viologens possessing higher (i.e., less negative) reduction potentials (E0 values). No
pH endpoint was observed (color formation for all pH values ≥ 0) for the two most easily
reduced viologens. These pH endpoint results are summarized in Table 1.1.
We propose that Em(RC+/ RC•) ≈ E0 (viologens) for the pH endpoints obtained in entries
4-8 of this table. As can be seen from Table 1.1, entry 3 through entry 8 viologens can be used to
detect Hcy and Cys selectively during lower pH. For example, benzylic viologen (entry 5) can be
used to detect Hcy selectively between pH 3.6 and pH 4.8 since there is no color change for Cys.
6

Table 1.1 The Minimum pH that α -Carbon Radicals Can Reduce Viologens
R N+

Entry

R (viologen)

N+ R

E0/mV

pH endpointa

pH(calc)b

pH endpoint of

of Hcy

of Hcy

Cys

1

2,4-dinitrophenyl

N.D.

none

﹤0

≤0

2

-CH2CN

-150

N.D.

0

≤0

3

-CH2CO2Et

-267

3.8

1.9

5.8

4

Ph-

-288

2.5

2.3

3.8

5

PhCH2-

-370

3.6

3.7

4.8

6

CH2=CHCH2-

-408

4.2

4.3

4.7

7

CH3(CH2)5CH2-

-415

4.3

4.4

5.8-7.0, 7.8

8

CH3-

-446

5.0

4.9

6.0-7.0, 8.2

a

Data from entries 4-8 show a linear correlation between E0 and pH endpoint. The best linear fit of this data gives
the empirical equation: E0 = -132.57 – 64.498 pH (R2 = 0.9872). See Figure 1.1.
b
pH(calc) are calculated from = (-153.3 – E0)/59.2 which represents the best fit of the data from entries 4-8 to the
theoretical equation E0(viologen) = E0(Hcy) + 59.2(pKobs – pH). We calculate an average value: [E0(Hcy) +
59.2pKobs]avg = [E0(viologen) + 59.2pH]avg = -153.3 mV.

Figure 1.1 Reduction Potential vs. pH Plot
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Interestingly, phenyl viologen (entry 4) is found to be an excellent reagent to selectively
detect Hcy and Cys. It can selectively detect Hcy and Cys not only in acidic conditions, but also
in basic conditions. From pH 9 to pH 12, Hcy shows a green color at first (and finally turned to
blue) whereas Cys shows blue. Especially at pH 11, Cys turns to blue color within 5 min of
gently refluxing, whereas Hcy turns to green after 10 min of gently refluxing.
It is worth noting that most of the viologens (from entry 4 to entry 8) we tested showed a
linear correlation between pH endpoint and E0 (standard reduction potential of α-carbon
radicals). This linear relation exactly matches what we expected from eqn (5). Using the
experimental data, we are able to get a line between pHmin and E0 (Figure 1.1).
We are currently unable to account for the discrepancy between the experimental endpoint
and pH(calc.) for entry 3. Noting that the diacid analog of this viologen has a reduction potential
of -410 mV, it is tempting to attribute the higher pH endpoint to hydrolysis of the ester moiety
(Scheme 1.6). However, various control experiments have revealed that ester hydrolysis is
minimal (< 5%) under the conditions of the viologen reduction experiment.

Scheme 1.6 Possible Hydrolysis of the Diester Viologen
The absence of a pH endpoint for entries 1 and 2 is consistent with pH(calc.) ≤ 0 for these
two viologens.
It seems that there are two color change ranges for Cys and alkyl viologens. Both of the
two alkyl viologens, methyl and heptyl viologens (entry 8 and entry 7), showed two color change
ranges when mixed with Cys (Table 1.1). The reason is unclear.
8

We also prepared dimethoxy viologen (Scheme 1.5, E0 = -651 mV, pH (calc) = 8.4) and
found that no color formation occurred in the pH range 8-11. A tempting interpretation of this
data is that the reduction potential of dimethoxy viologen is more negative than E0(RC+/ RC•),
and therefore there is no pH at which the mid-point potential Em(RC+/ RC•) is negative enough
for dimethoxy viologen reduction to occur. This interpretation is represented graphically in
Figure 1.2.

Cl–
Ph N+

Cl–
CH3 N+

Cl–
N+ Ph

-288 mV

Cl–
N+ CH3

-446 mV

E°(RC+/RC•)
BF4–
CH3O N+

BF4–
N+ OCH3

-651 mV
2.3

4.9

8.4

pH

Figure 1.2 Reduction Potential vs. Whole pH Range
This interpretation would allow us to bracket the standard potential of the homocysteinederived α-carbon radical as: -651 mV < E0(RC+/ RC•) < -446 mV. While the upper value of this
bracketing is certainly valid (-446 mV for MV2+ falls on the linear part of the Em(RC+/ RC•) vs.
pH curve), the lower value is uncertain. At pH 11 there should be color formation associated
with formation of the disulfide radical anion ([HcyS-SHcy] •–, E0 ≈ -1700 mV for [CysS-SCys] •).
9

Lack of color formation at pH 11 probably suggests that dimethoxy viologen is not stable at
this pH. Indeed, gently refluxing a solution of dimethoxy viologen at pH 11 leads to complete
conversion of the viologen to a mixture of decomposition products from which 4,4’-bipyridine
can be isolated in 80-85% yield (Scheme 1.7).

Scheme 1.7 Decomposition of Dimethoxy Viologen under Basic Conditions
Net demethoxylation of dimethoxy viologen might occur by a β-elimination pathway
where a pyridine leaving group is ejected and the methoxyl group is oxidized to formaldehyde
(Scheme 1.8).[15] An interesting possibility to explore is the preparation of a stable analog of
dimethoxy viologen lacking this β-elimination decomposition pathway.

Scheme 1.8 Mechanism for the Decomposition of Dimethoxy Viologen

Scheme 1.9 Preparation of N-acetyl homocysteine
We prepared N-acetyl homocysteine according to a known procedure (Scheme 1.9).[16]
Since the amide group cannot be protonated under experimental conditions, the reduction
potential of N-acetyl Hcy derived α-carbon radicals is expected to be pH independent. However,
we are surprisingly to find out that no color change could be observed with methyl viologen at
neutral or slightly acidic conditions, indicating that the reducing α-carbon radicals were never
formed probably due to the weaker captodative effect of N-acetyl Hcy derived α-carbon radicals.
10

1.6 Conclusion
In order to better understand the colorimetric detection method of Hcy using viologens, a
thermodynamic model for the pH dependence of the effective reduction potential of Hcy derived
α-carbon radicals has been proposed. And using viologen indicators of varying reduction
potentials, we demonstrate that colorimetric changes occur at experimental pH values consistent
with the model.
We found that viologen reduction mediated by α-amino carbon-centered radicals can
occur under acidic conditions. The reduction potential of α-carbon radicals was found to be pH
dependent, and it shows a linear correlation between the reduction potential and pH for Hcy. The
pH profiles of Cys and Hcy have been established for six viologens. Most of the viologens can
be used to selectively detect Hcy and Cys under acidic conditions. The determination of standard
reduction potentials of α-carbon radicals is currently underway in our lab.
1.7 Experimental
1.7.1 General Experimental
The preparation experiments were performed under a nitrogen atmosphere in oven- and/or
flame-dried glassware using a Vacuum Atmospheres dry box or by using standard Schlenk
techniques. Solvents used as reaction media were distilled immediately before use: acetonitrile
were distilled from Na/benzophenone ketyl. Ethyl bromoacetate was purchased from Alfa Aesar.
NMR solvent (D2O, CDCl3) was purchased from Cambridge Isotope Laboratories, Inc. All of the
other reagents were purchased from Sigma-Aldrich and used without any further purification.
1

H spectra was recorded on a Bruker AV-400 (400 MHz 1H) or a Bruker AC-250 (250

MHz 1H) spectrometer in deuterated solvents using the solvent residual protons as an internal
reference (H2O: 4.68 ppm, CDCl3: 7.26 ppm) for 1H NMR or using DSS as an internal reference
for

13

C NMR (CDCl3: 77.0 ppm, t for

13

C NMR). Chemical shifts (δ) are given in parts per
11

million down from tetramethylsilane (TMS). Data for 1H NMR spectra are reported as follows:
chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quin
=quintet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets,
ddt = doublet of doublet of triplets, m = multiplet), coupling constant (Hz), and integration.
The buffer solution that we use in the experiment is shown in Table 1.2.
Table 1.2 Buffer Components
pH range

Buffer Component
(1+2)

Concentration 1

Concentration 2

1.0--2.2

HCl + KCl

x ml 0.2 M, dilute to 100 ml

0.05 M

x ml 0.1 M

(100-x) ml 0.2 M

Citric Acid +
2.3--6.9
Na2HPO4
7.0--9.0

Tris + HCl

0.05 M

x ml 0.1 M, dilute to 100 ml

10.0--11.0

NaHCO3 + NaOH

0.025 M

x ml 0.1 M, dilute to 100 ml

12.0--13.0

NaOH + KCl

x ml 0.2 M, dilute to 100 ml

0.05 M

1.7.2 Preparative Procedures
General procedure for the preparation of viologens:[13a] A mixture of alkyl bromide
(10 equiv) and 4,4’-bipyridine (1 equiv) were heated to reflux in anhydrous acetonitrile under
nitrogen for 4 to 20 hours. After the reaction mixture was cooled down to room temperature, the
precipitate was filtered off and purified by recrystallization from ethanol.
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1,1’-Bis(cyanomethyl)-4,4’-bipyridinium

dibromide

(entry

2):[13b]

Under

Ar

atmosphere 4,4’-bipyridine (0.781g, 0.05 mol) and 2-bromo acetonitrile (1.799g, 0.015 mol)
were dissolved in anhydrous DMF (50 mL). The mixture was heated at 60 oC for 16 hours, and
then cooled to room temperature. 200 mL of acetone were added and the reaction mixture
allowed to stand overnight at room temperature. The yellow precipitate was filtered, washed with
acetone, and dried under vacuum. The product (1.46g, 74%) was obtained as a yellow powder.
1

H NMR (400 MHz, D2O): δ 9.26 (d, J = 7.0 Hz, 4H), 8.64 (d, J = 7.0 Hz, 4H), 5.98 (s, 4H,

diminished integration due to partial deuterium exchange). 13C NMR (100 MHz, D2O): δ 151.7,
146.3, 127.9, 112.8, 48.2.
1,1’-Bis(2-ethoxy-2-oxoethyl)-4,4’-bipyridinium dibromide (entry 3): Following the
general procedure, ethyl bromoacetate (3.55 mL, 0.032 mol) and 4,4’-bipyridine (0.50 g, 0.0032
mol) were refluxed in anhydrous acetonitrile (60 mL) for 20 hours. The product (1.24 g, 80%)
was obtained as cubic yellow crystals. 1H NMR (400 MHz, D2O): δ 9.07 (d, J = 6.4 Hz, 4H),
8.59 (d, J = 6.4 Hz, 4H), 5.63 (s, 4H, diminished integration due to partial deuterium exchange),
4.29 (q, J = 7.1 Hz, 4H), 1.24 (t, J = 7.1 Hz, 6H).
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C NMR (100 MHz, D2O): δ 166.8, 151.2,

147.1, 127.1, 64.3, 61.2, 13.3.
1,1’-Diallyl-4,4’-bipyridinium dibromide (entry 6): Following the general procedure,
allyl bromide (1.77 mL, 0.02 mol) and 4,4’-bipyridine (0.32 g, 0.002 mol) were refluxed in
anhydrous acetonitrile (40 mL) for 4 hours. The product (0.53 g, 65%) was obtained as deep
yellow needles. 1H NMR (400 MHz, D2O): δ 9.05 (d, J = 6.8 Hz, 4H), 8.50 (d, J = 6.8 Hz, 4H),
6.10-6.18 (m, 2H), 5.54 (dd, J1 = 10 Hz, J2 = 17 Hz, 4H), 5.29 (d, J = 6.4 Hz, 4H). 13C NMR (100
MHz, D2O): δ 150.4, 145.6, 129.6, 127.1, 123.8, 63.7.
4,4’-dipyridyl 1,1’-dioxide: Following the literature procedure,[14] 4,4’-bipyridine (5 g,
0.032 mol) in glacial acetic acid (25 mL) was heated to 70oC. After complete dissolution of the
13

bipyridine, a 30% solution of H2O2 in H2O (3.64 g, 0.032 mol) was added dropwise, and the
mixture was stirred at 70 oC for 6 hours. After dropwise addition of a second equivalent of H2O2,
the mixture was stirred at 70 oC for another 24 hours. The solvent was then removed, and the
remainder was neutralized with saturated aqueous NaHCO3. Recrystallization from water
afforded the product as the hemihydrate as yellow needles (5 g, 76%).

1

H NMR (400 MHz,

D2O): δ 8.32 (d, J = 6.9 Hz, 4H), 7.86 (d, J = 6.9 Hz, 4H). 13C NMR (100 MHz, D2O): δ 139.5,
137.9, 124.7.
1,1’-Dimethoxy-4,4’-bipyridinium bis[tetrafluoroborate]: Following the literature proprocedure,[14] trimethyloxonium tetrafluoroborate (847 mg, 5.70 mmol) and 4,4’-dipyridyl 1,1’dioxide (511 mg, 2.49 mmol) were stirred in 10 mL of acetonitrile for 4 hours. Recrystallization
from acetonitrile afforded the product (620 mg 65%) as colorless prisms. 1H NMR(400 MHz,
D2O): δ 9.38 (d, J = 7.0 Hz, 4H), 8.59 (d, J = 7.0 Hz, 4H), 4.50 (s, 6H).
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C NMR (100 MHz,

D2O): δ 149.2, 141.4, 128.4, 69.8.
N-acetyl Hcy: Following the known procedure,[16] N-acetyl Hcythiolactone (1.0 g, 6.3
mmol) was dissolved in an aqueous NaOH solution (6.4 ml, 3.0 M) and THF (1.6 ml), and the
resulting mixture was stirred at 0oC for half an hour. After which the mixture was acidified by 3
N HCl to pH 0. Then the mixture was extracted with ethyl acetate (3×20 ml), and the combined
organic extracts were washed with brine, dried (MgSO4), filtered and concentrated to give the
product (0.9 g, 81%) as white powders.
1.7.3 Control Experiments


Entry 3 Hydrolysis
1. 1,1’-Bis(2-ethoxy-2-oxoethyl)-4,4’-bipyridinium dibromide (9.8 mg, 0.02 mmol) was

dissolved in 5 mL of sulfuric acid (pH = 3.0, solvent: D2O), and the resulting mixture was gently
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refluxed for one hour. An aliquot of the resulting mixture was examined by 1H NMR. The
spectrum showed that less than 5% hydrolysis product was formed.
2. The viologen substrate (9.8 mg, 0.02 mmol) was dissolved in 5 mL of hydrochloric acid
(pH = 2.3, solvent: D2O), and the resulting mixture was gently refluxed for one hour. An aliquot
of the resulting mixture was examined by 1H NMR. A similar spectrum was obtained.
3. The viologen substrate (9.8 mg, 0.02 mmol) and Hcy (11.5 mg, 0.085mmol) were
dissolved in 5 ml of citric acid and Na2HPO4 buffer (pH = 3.8, solvent: D2O), and the resulting
mixture was gently refluxed for one hour. An aliquot of the resulting mixture was examined by
1

H NMR. A similar spectrum was obtained except for the extra Hcy and citric acid peaks.



Dimethoxy Viologen Control Experiment
1. The substrate dimethoxy viologen (7.8 mg, 0.02 mmol) was dissolved in 5 ml of sodium

hydroxide solution (pH = 11.0, solvent: D2O), and the resulting mixture was gently refluxed for
one hour. An aliquot of the resulting mixture was examined by 1H NMR. The spectrum indicated
complete conversion of the viologen substrate to unidentified decomposition products. 4,4’dipyridyl 1,1’-dioxide was not present in the mixture.
2. The substrate dimethoxy viologen (7.8 mg, 0.02 mmol) and Hcy (11.5 mg, 0.085
mmol) were dissolved in 5 ml of sodium hydroxide solution (pH = 11.0, solvent: D2O), and the
resulting mixture was gently refluxed for one hour. An aliquot of the resulting mixture was
examined by 1H NMR. A similar spectrum was obtained except for the extra Hcy peaks.
3. The substrate dimethoxy viologen (40 mg, 0.10 mmol) was dissolved in 5 ml of the
buffer solution (pH = 11.0, components: NaOH + NaHCO3), and the resulting mixture was
gently refluxed for one hour. After cooled down to room temperature, the mixture was extracted
with chloroform (3  5 ml). The combined organic solvent was dried (MgSO4), filtered and
concentrated to give 4,4’-bipyridine (13.0 mg, 82%) as the major product.
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4. The substrate dimethoxy viologen (16 mg, 0.04 mmol) and Hcy (23 mg, 0.17 mmol)
were dissolved in 10 ml of the buffer solution (pH = 11.0, component: NaOH + NaHCO3), and
the resulting mixture was gently refluxed for one hour. After cooled down to room temperature,
the mixture was extracted with chloroform (3  10 ml). The combined organic solvent was dried
(MgSO4), filtered and concentrated to give 4,4’-bipyridine (5.4 mg, 85%) as the major product.
1

H NMR(400 MHz, CDCl3): δ 8.47 (d, J = 6.1 Hz, 4H), 7.57 (d, J = 6.1 Hz, 4H). 13C NMR (100

MHz, CDCl3): δ 150.7, 145.5, 121.4.
5. The substrate dimethoxy viologen (16 mg, 0.04 mmol) was dissolved in 10 ml of
sodium hydroxide solution (pH = 12.0), and the resulting mixture was gently refluxed for one
hour. After cooled down to room temperature, the mixture was extracted with chloroform (3  10
ml). The combined organic solvent was dried (MgSO4), filtered and concentrated to give 4,4’bipyridine (5.2mg, 82%) as the major product. 1H NMR(400 MHz, CDCl3): δ 8.47 (d, J = 6.1
Hz, 4H), 7.57 (d, J = 6.1 Hz, 4H). 13C NMR (100 MHz, CDCl3): δ 150.7, 145.5, 121.4.
1.7.4 Spectral Data
Spectral data are shown from the next page.
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CHAPTER 2 STUDIES ON THE SYNTHESIS OF BICYCLO[3.3.1]NONANES
2.1 Introduction
The framework of bicyclo[3.3.1]nonanes are quite common in nature as a constituent of
many naturally and biologically active products or their metabolites.[1] Biosynthetic pathway of
many sesquiterpenoids and other naturally occurring materials involve formation and
transformation of this framework.[2]
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Scheme 2.1 Conformations of Bicyclo[3.3.1]nonanes
Moreover, the bicyclo[3.3.1]nonane system shows interesting conformational features
(Scheme 2.1).[3] Three groups of conformations must be envisaged: (1) the rigid double-chair
(cc), in which a severe interaction between H3a and H7a occurs, (2) the rigid chair-boats (cb, bc),
and (3) the flexible double-boat conformations (bb). It is obvious that substituents at the 3- and
7-positions have a strong influence on the conformational preferences. The unsubstituted, the 3eor 7e-, and the 3e,7e-substituted compounds occur predominantly in a strongly flattened cc
conformation. A 3a-or 7a-substituent forces the wing concerned into the boat conformation.
When both the 3a-and 7a-positions are substituted, the conformational preference depends on the
steric requirements of these substituents. With bulky substituents, the bb conformation
predominates, whereas with small substituents the cb and the bc conformations may also be
populated.
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Due to this important structural feature, the chemistry of bicyclo[3.3.1]nonanes has
received much attention from synthetic and theoretical points of view. Indeed, a lot of efficient
and highly stereoselective synthetic methods to access this framework have been established.[4]
The synthetic methods typically include annulation of cyclohexanone derivatives, annulation of
cyclooctane derivatives, tandem Michael addition and related reactions, ring cleavage of
adamantane derivatives, et al. However, introduction of a stereocenter at the one-carbon bridge
has rarely been reported and remains an unsolved problem. Herein, our research will be focused
on this problem.
2.2 First Generation on Approach to Bicyclo[3.3.1]nonanes

Scheme 2.2 Retrosynthetic Analysis of the Tricyclic Core of Vinigrol
Interest in ring system 2.01, present in the natural product vinigrol[5] prompted us to
investigate the two-carbon ring expansion of a tricyclic precursor 2.02 which we envisioned
could be prepared from an appropriately substituted bicyclo[3.3.1]nonane 2.03a via an
intramolecular alkylation (Scheme 2.2). According to Baldwin, such a 6-exo-tet cyclization
should prove favorable.[6] Since the stereochemistry at the one-carbon bridge of the
bicyclo[3.3.1]nonane is critical for the intramolecular alkylation, we explored this
stereoselectivity carefully.
The bicyclic 2.03a in turn could be prepared by an intermolecular alkylation between 2.04
and activated form of acetone. If the reaction occurs via a SN2 pathway, we will be able to
construct 2.03a with the desired stereoselectivity.
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As the first step in the synthesis (Scheme 2.3), the allyl alcohol was prepared by reduction
of the commercially available 2-cyclohexenone with LAH in Et2O. Subsequent hydroxy directed
epoxidation[7] afforded the cis-epoxide alcohol 2.05. Next, considering the possible
regioselectivity issue associated with allyl metal opening of the epoxide 2.05, the reaction was
carefully studied with various conditions. Although this regioselectivity problem was
encountered by the previous literature,[8] no general method to solve the problem has yet been
reported.

Scheme 2.3 Initial Efforts toward the Synthesis of Bicyclo[3.3.1]nonane
As can be seen in Table 2.1, when compound 2.05 was treated with allyl cuprates or
higher order cuprates, the 1,2-diol was formed as the major product. In comparison, allyl
magnesium bromide with copper iodide as the catalyst gave the 1,3-diol 2.06 as the major
product (Table 2.1, entry 2). THF seems to be harmful to the regioselectivity (1,2-diol is the
major product for entry 1 and entry 4). Although the selectivity is poor, the yield is acceptable
and the two regioisomers can be easily separated by treating the mixture with sodium periodate.
Double tosylation of the diol 2.06 gave 2.07.
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Efforts towards the synthesis of the bicyclic 2.09 from sulfonate ester 2.07 were
unsuccessful. Both tosylate 2.07 and mesylate 2.08 did not react at all. The reluctance of 2.07 or
2.08 to undergo alkylation may be due to the steric hindrance of the electrophilic carbon, which
is a secondary carbon next to a tertiary carbon. We tried to facilitate the reaction by replacing
tosylate with triflate, a better leaving group. Unfortunately, the triflate was readily decomposed
in the preparation.
Table 2.1 Allyl-Metal Opening of the Epoxide
Ratioa
Entry

Allyl Metal

Additive

Solvent

Temp.

Yieldb

(1,3/1,2-diol)

a
b

1

None

THF

-40oC

1:2

86%

2

CuI

Et2O

-40oC

5:4

90%

3

CuI

Et2O : THF= 6:1

-40oC

4:5

90%

4

CuI

THF

-40oC

5:6

91%

5

None

Et2O

25 oC

1:1

90%

Ratio is based on the crude products NMR
This is the total yield of the two diols

2.3 Revised Approach to Bicyclo[3.3.1]nonanes
2.3.1 One-Carbon Bridge Stereocontrol in Forming Bicyclo[3.3.1]nonanes

Scheme 2.4 Retrosynthetic Analysis of the Tricyclic Core of Vinigrol
Different from the first generation, we envisioned that the bicyclo[3.3.1]nonanol 2.12a,
whose hydroxyl group does present in the natural product vinigrol, could be generated by a
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Robinson annulation reaction (Scheme 2.4). Thus we explored the Robinson annulation depicted
schematically in structure 2.13 as a route to 2.12a paying special attention to the stereochemistry
of the allyl group attached to the one-carbon bridge.

Scheme 2.5 Stereochemistry Governed by the Competing Aldol Reactions
Stereochemistry at the one-carbon bridge will be governed by the competition of aldol ring
closure reactions of diastereomeric intermediates 2.15a and 2.15b formed from Michael adduct
2.14 (Scheme 2.5). There are several lines of lines of reasoning that might lead one to expect that
the aldol ring closure of 2.15a, leading to the desired stereochemistry present in 2.12a, might be
the favored pathway. First, the reactive conformer of 2.15a (equatorial allyl) should be more
stable than that of 2.15b (axial allyl). Second, Robinson annulation product 2.12a (derived from
2.15a) is more stable than its epimer 2.12b (derived from 2.15b) due to the enolization of the
keto ester which removes a 1,3-diaxial interaction involving the allyl group. Indeed, two similar
Robinson annulations previously reported provide precedent for the major product possessing the
desired stereochemistry 2.12a. Theobald reported that 2.16a is the major product formed by
annulation of (S)-carvone (2.17) with ethyl acetoacetate, followed by saponification and
decarboxylation.[9] Kraus reported that 2.18a was the major product (>20:1 diastereoselectivity)
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formed from the analogous annulation/decarboxylation sequence utilizing 2-allyl-5-methyl-2cyclohexenone (2.19).[10]
Table 2.2 Stereochemical Outcome of Robinson Annulations Leading to
Bicyclo[3.3.1]nonanes
EtO2C
O

+

R1

R2
O

3

R

NaOMe

R1

MeO2C

MeOH
reflux

HO

H
OH

H

H

MeO2C
+

HO

H
R1
OH

H

3

H
3

2.20, R1=allyl, R2=R3=H

R
R2
syn
minor
2.12a

2.12b

2.19, R1=allyl, R2=Me, R3=H

2.21a

2.21b

2.22, R1=allyl, R2=H, R3=Me

2.23a

2.23b

2.24, R1=-(CH2)3OH, R2=R3=H
2.17, R1=Me, R2=CH3C=CH2, R3=H

2.25a

2.25b

2.26a

2.26b

Entry

Ratio (a/b)a

Starting material

R
R2
anti
major

Total yield (%)

1

2.20b

1:4.3

54

2

2.19c

1:3.5

42

3

2.22d

1:4.9

31

4

2.24e

1:5

43

5

2.17f

1:4

56

a

The ratio is based upon the 1H NMR of the crude product.
The compound is prepared according to literature.[11]
c
The compound is prepared according to literature.[12]
d
The compound is prepared by methylation of compound 2.20.[13]
e
The compound is prepared by hydroboration-oxidation of compound 2.20 using Cy2BH·THF according to a known
procedure.[14]
f
(S)-carvone is commercially available.
b

To our surprise the Robinson annulation reaction of ethyl acetoacetate with 2-allyl-2cyclohexenone (2.20) gave 2.12b (anti), rather than 2.12a (syn), as the major product (Table 2.2,
entry 1). Repeating the Robinson annulation originally reported by Kraus, we were also surprised
to find that 2.21b (anti) was the major diastereomer obtained in the reaction of ethyl acetoacetate
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with 2-allyl-5-methyl-2-cyclohexenone, 2.19 (entry 2). In order to directly compare our
selectivity to the Kraus result, the 2.21b/2.21a mixture was decarboxylated to produce a
2.18b/2.18a mixture with the same diastereomer ratio and 2.18b (anti) rather than 2.18a (syn) as
the major product. Compound 2.23b (anti) was the major diastereomer obtained in the reaction
of ethyl acetoacetate with 2-allyl-6-methyl-2-cyclohexenone, 2.22 (entry 3). Neither the
substituent on cyclohexane ring (entries 1-3) nor the substituent at the one carbon bridge (entries
4-5) significantly influences stereoselectivity. In the reaction of ethyl acetoacetate with 2.24 (3hydroxypropyl is the substituent at the one-carbon bridge) and (S)-carvone (2.17), the anti
diastereomers 2.25b and 2.26b are the major products formed. The configuration of the one
carbon bridge center has been unambiguously assigned according to the X-ray crystal analysis of
compounds 2.21b, 2.23b, and 2.26b (Figure 2.1, 2.2 and 2.3).

Scheme 2.6 Comparitive Features of the Two Diastereomers Formed from the Robinson
Annulation
It is worth mentioning that, for a mixture of diastereomers formed in a Robinson annulation
reaction, we can quickly assign the configuration of the one-carbon bridge stereocenter on the
basis of the relative positions of NMR signals for the enolic protons and carbons (O2-H and C3;
see Scheme 2.6). In each case that we’ve examined, both the O2-H and C3 chemical shifts of the
minor diastereomer (syn, a series) are downfield to those of the major diastereomer (anti, b
series). Another trend that we have observed is that the minor diastereomers are consistently less
polar (higher Rf on TLC, shorter retention time in column chromatography) than the major diast35

Figure 2.1 ORTEP Plot of Bicyclo[3.3.1]nonane 2.21b
36

Figure 2.2 ORTEP Plot of Bicyclo[3.3.1]nonane 2.23b
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Figure 2.3 ORTEP Plot of Bicyclo[3.3.1]nonane 2.26b
38

ereomers. Collectively, this data is consistent with conformational equilibrium where the relative
stability of hydrogen-bonded conformers is greater for the minor diastereomers. The one-carbon
bridge substituent could influence such an equilibrium by sterically destabilizing non-hydrogen
bonded conformers.
The unanticipated stereoselectivity appears to be kinetically controlled since major anti
products (2.12b, 2.21b, 2.23b, 2.25b, and 2.26b) are higher in energy than diastereomeric minor
syn products (2.12a, 2.21a, 2.23a, 2.25a, and 2.26a). Stereoselectivity also correlates with the
expected rate of the aldol ring closure where the major products result from reactions which
place the substituent α to the reacting ketone anti to the approaching enolate (e.g., 2.15b→2.12b
in Scheme 2.5).
2.3.2 Epimerization of the One-Carbon Bridge Stereocenter
While exploring the reaction chemistry of Robinson annulation products we discovered an
interesting epimerization reaction which might provide an alternative stereocontrol motif which
can influence the stereochemistry of the substituent at the one carbon bridge. It turns out that the
decarboxylation reaction of 2.27 is slow and base sensitive (see Table 2.3).[15] Treatment of a
1:4.3 mixture of 2.27a and 2.27b with refluxing methanolic KOH (3 equiv, 24 hr) produced a 1:1
mixture of decarboxylation products 2.28a and 2.28b (Table 2.3, entry 3). In contrast, if 2.27
was treated with slightly excess base, no epimerization was observed (Table 2.3, entries 1-2).

Scheme 2.7 Preparation of the Crystalline Diols 2.30 Derivatived from Ketone 2.28
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Subjection of diastereomerically pure 2.28a or 2.28b to the same reaction conditions leads
to the same 1:1 mixture (Table 2.3, entries 4-5) suggesting that the final product ratio represents
thermodynamic control. We propose that this isomerization takes place via a retro-aldol reaction
followed by based catalyzed epimerization of the ring opened diketones.
The epimerized products 2.28a and 2.28b has been confirmed by single crystal X-ray
analysis of its corresponding derivatives 2.30a and 2.30b (see Scheme 2.7 for the reactions, and
see Figure 2.4 and Figure 2.5 for the crystal structures).
Table 2.3 Stereochemical Outcome of Base-Catalyzed Epimerization of the One-Carbon
Bridge Stereocenter

a

Entry

Substrate (ratio)

Reaction Condition

Product (ratio)a

Total Yield

1

2.27 (1 : 4.3)

1.1 eq. KOH(aq), MeOH, 12hs

2.28 (1 : 4.3)

60%

2

2.27 (1 : 4.3)

1.5 eq. KOH(aq), MeOH, 24hs

2.28 (1 : 4.3)

96%

3

2.27 (1 : 4.3)

3 eq. KOH(aq), MeOH, 24hs

2.28 (1 : 1)

90%

4

2.28a (pure)

3 eq. KOH(aq), MeOH, 24hs

2.28 (1 : 1)

91%

5

2.28b (pure)

3 eq. KOH(aq), MeOH, 24hs

2.28 (1 : 1)

90%

6

2.27 (1:4.3)

6 eq. KOH(aq), MeOH, 24hs

2.28 (1 : 1)

70%

The ratio is based upon the 1H NMR of the crude products
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Figure 2.4 ORTEP Plot of Bicyclo[3.3.1]nonane 2.30a
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Figure 2.5 ORTEP Plot of Bicyclo[3.3.1]nonane 2.30b
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Table 2.4 Base-catalyzed Epimerization of Bicyclo[3.3.1]nonane Products 2.12 Aimed at
Preventing Decarboxylation
Substrate (ratio)

Reaction Condition

Product (ratio)a

Total Yield

2.12 (1:4.3)

MeONa (6 eq.), MeOH, 84hs reflux

2.12 (1:3)

40%

2.12 (1:1)

38%

2.12 (1:4.3)
a

t

BuOK (6 eq.), tBuOH, 84hs reflux

The ratio is based upon the 1H NMR of the crude products

Table 2.5 Robinson Annulation Reactions Aimed at Producing Bicyclo[3.3.1]nonane
Products Resistant to Base-mediated Decarboxylation

a

Product

Ratio (b/a)a

Total yield (%)

2.31

2.5:1

80

2.32

2.7:1

74

The ratio is based upon the 1H NMR of the crude products

A similar base-catalyzed epimerization conducted on a mixture of 2.12b and 2.12a might
change the 4.3:1 2.12b/2.12a kinetic ratio to a thermodynamic ratio favoring the more stable
isomer 2.12a. Unfortunately, the base-mediated decarboxylation reaction which takes place
under these conditions prevents such an epimerization from being realized. In order to prevent
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this decarboxylation from being occurred, compound 2.12 was treated with excess MeONa in
refluxing MeOH without the presence of water. Disappointingly, little epimerization was
observed with a low recovery of 2.12 (Table 2.4). In comparison, when tBuOK in tBuOH was
used, the epimerization realized but with a low yield (Table 2.4), which limits the use of
epimerization as a practical stereochemical control element.
We reasoned that there may be other base stable electron-withdrawing groups still capable
of promoting the enolization that stabilizes the desired diastereomer of the Robinson annulation
reaction. Thus, we looked at the Robinson annulation of carvone with acetone derivative
possessing an α carbon substituted with either a carboxamide or cyano group. We obtained
kinetic product ratios similar to those obtained using β-keto-esters (Table 2.5).

Scheme 2.8 Stereoselectivity Reversal via Base-catalyzed Epimerization
Base-catalyzed epimerization (6 equiv KOH, refluxing MeOH, 24 hrs) converted the 2.5:1
2.31b:2.31a mixture obtained from the Robinson annulation to a 3:1 2.31a:2.31b mixture
(Scheme 2.8). Base-catalyzed epimerization of pure 2.31b produced the same 3:1 mixture where
2.31a was the major component. Since the keto form predominated for cyano-substituted
Robinson annulation products 2.32a and 2.32b, an epimerization reaction favoring 2.32a was not
considered a promising prospect.
2.4 Computational Mechanism Studies on the Robinson Annulations
Although the basic reaction sequence of the Robinson annulation has been well
established,[16] the mechanistic details of the reaction that forms bicyclo[3.3.1]nonanes remain an
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unsolved problem. Additionally, the subtle differences in reaction pathways leading to the two
diastereomeric products and in favor of the anti products are unclear. Therefore, we did a
combined experimental and computational study that examines the origins of the
diastereoselection in the base catalyzed Robinson annulations leading to the framework of
bicyclo[3.3.1]nonanes.
Table 2.6 Effects of Basis Sets for Compound 2.21b
Bond length

O1-

C1-

C2-

C3-

C7-

C10-

O2-H--

C1-O1-

C2-C1-

(Å)/angle (°)

C1

C2

C3

C4

C13

C11

-O4

H

C9

Crystal

1.433 1.536

1.488

1.356

1.537

1.498

1.620

107.1

108.1

6-31g(d)

1.436 1.548

1.504

1.370

1.534

1.507

1.690

107.5

108.0

6-311g(d)

1.472 1.546

1.499

1.368

1.538

1.509

1.726

109.8

108.4

6-311++G(d,p)

1.439 1.546

1.502

1.366

1.532

1.505

1.694

108.7

108.0

To be sure that the DFT method[17] (B3LYP) is appropriate for this series of compounds,
we started by calculating the ground state of compound 2.21b, whose crystal structure has been
obtained previously. Indeed, the optimized structure of compound 2.21b has a very similar
geometry, including bond lengths, bond angles and hydrogen bonding, to the crystal structure we
have obtained (see Figure 2.1 for the atom number). These results are summarized in Table 2.6.
Additional calculations with basis sets containing diffuse functions at the B3LYP/6-311+G(d)
and B3LYP/6-311++G(d,p) levels were also performed for compound 2.21b (shown in Table
2.6). These additional calculations gave similar relative energies and parameters as those
obtained by the B3LYP/6-31G(d) method, suggesting that B3LYP/6-31G(d) is appropriate for
studying the bicyclo[3.3.1]nonanes.
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To better understand whether the reaction is kinetically controlled, we utilized DFT
calculations (B3LYP/6-31G+d) to examine the energies and structures of the two diastereomeric
products 2.33a and 2.33b (see Table 2.7 for the structure of 2.33a and 2.33b). The result of the
calculations indicates that the syn product 2.33a is indeed the thermodynamically favored
product, lying approximately 1 kcalmol-1 lower in energy than the anti product 2.33b.
Furthermore, their corresponding anion species that are formed in the reaction conditions have
similar energy differences (2.47 vs. 2.46, Figure 2.6).
The solvation energies for 2.46 and 2.47 in methanol were also calculated by single point
calculations on the optimized structures with the polarized continuum model (PCM). The energy
difference for them is similar to the difference in gas phase, so we stopped calculating solvation
energies for other species.
In the first step of the reaction, the Michael addition intermediate 2.34’ will be formed,
leaving the β-keto ester branch at the axial position of the half-chair conformation of the
cyclohexene ring (Scheme 2.9). After the ring conformational exchange, the Michael addition
product will adopt its lowest conformation, leaving the β-keto ester branch at the equatorial
position of the cyclohexene moiety yielding 2.34 and 2.35, which undergo fast epimerization
with each other under basic conditions.

Scheme 2.9 Species Formed in the Reaction Mixture
Figure 2.6 shows the computed energy surface for the base catalyzed Robinson
annulations to form bicyclo[3.3.1]nonanes. The optimized structures of the transition states
involved in this reaction are also given in Figure 2.6. Two possible pathways leading to the two
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Figure 2.6 Reaction Energy Profile of Robinson Annulations
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diastereomeric products have been found (Figure 2.6). Pathway 1 started from the enolate 2.34,
and then an intramolecular proton transfer process took place to form the aldol precursor 2.37. A
favorable six-membered ring transition state TS2.36 adopting chair conformation was located
during this transformation. Pathway 2 started from the enolate 2.35, and a similar proton transfer
from the methyl ketone moiety to the cyclohexyl enolate was located yielding the aldol precursor
2.39. Pathway 1 is more favorable because the transferred proton in the transition state TS2.36 is
delivered axially to the cyclohexyl enolate moiety, and it is involved in a favorable chair
conformation. In contrast, TS2.38 of pathway 2 is less favorable because equatorial delivery of
the proton from the methyl ketone to the cyclohexene ring results in poor orbital overlap. In
order to maintain good orbital overlap, the cyclohexene ring of the transition state has to adopt a
twisted boat conformation (Figure 2.6). Indeed, the activation energy of this step of pathway 2 is
20.8 kcalmol-1, which is 9.7 kcalmol-1 higher than that of pathway 1.
The intrinsic reaction coordinate (IRC)[18] calculation demonstrates that both TS2.36 and
TS2.38 directly connect the corresponding starting material and products without involving the
formation of any other intermediate. In TS2.36, the C1-C2 π bond is forming, C4-C5 π bond is
breaking, and H3 is transferring from the C1 atom of the methyl ketone to the C4 atom of the
cyclohexene ring. A similar phenomenon is observed in TS2.38.
Following the proton transfer step, the intramolecular aldol reaction will take place in
both pathways to form 2.42 and 2.45. Because the reactive conformations of the aldol substrates
leave the β-keto ester branch at the axial position, neither 2.37 nor 2.39 could be the appropriate
substrate. Instead, their corresponding conformational isomers 2.40 and 2.43 will be the reactive
species. The activation barrier of aldol ring closure of pathway 1 is only 9.9 kcalmol-1, which is
1.2 kcalmol-1 lower than that of the intramolecular proton transfer step. In comparison, the
activation energy of aldol ring closure of pathway 2 is 9.3 kcalmol-1, which is 11.5 kcalmol-1
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lower than that of the intramolecular proton transfer step. In addition, we previously expected the
aldol ring closure step would correlate with the stereoselectivity. However, activation energies of
the aldol ring closures of both pathways are very close, with only 0.6 kcalmol-1 difference.
Obviously, the intramolecular proton transfer step is the rate determining step in both
pathways. Moreover, the activation energy of pathway 1 is 9.7 kcalmol-1 lower than that of
pathway 2, suggesting that the product of pathway 1 will be favored, which is consistent with the
observed experimental results.
Table 2.7 Solvent Effects on the Stereochemical Outcome of Robinson Annulations

a

Conditions

Product

Ratio (a/b)a

Total yield

1

2.33

1:3.9

56%

2

2.48

1:3.3

30%

The ratio is based on the 1H NMR of the crude products

It is worth mentioning that the intramolecular proton transfer step of both pathway 1 and
2 could be a solvent-assisted intermolecular proton transfer process. This is especially possible in
our experimental conditions, using methanol as the solvent. If this is the case, the rate
determining step of the reaction could be the aldol ring closure. However, we ruled out this
possibility by successfully conducting the reaction in an aprotic solvent---THF. The experimental
result is summarized in Table 2.7. As can be seen in the table, the product ratio remains almost
unchanged in both conditions, though the yield in THF is slightly lower. Therefore, the solvent
has little effect on the stereoselectivity of the reaction. If solvent-assisted proton transfer process
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Figure 2.7 Potential Energy Profile of the Intramolecular Proton Transfer Step
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did occur in the reaction, it did not bring the activation barrier lower than the aldol ring closure
process, which would lead to an approximately 1:1 ratio of the two products because the
activation energy of the aldol reaction step of both pathways is very close.
Another possible intramolecular proton transfer process after the formation of the Michael
adduct 2.34 needs to be considered because the most acidic proton within the molecule is the βketo ester proton, and not the methyl ketone proton. Figure 2.7 shows the computed energy
surface for this intramolecular proton transfer process. The optimized structures of the transition
states involved in this transformation are also given in the figure. Pathway 3 starts from the
enolate 2.34, and leads to the β-keto ester stabilized anion 2.50 via the transition state TS2.49,
which has a cis-fused 6,4-membered ring conformation. The activation energy for this process is
32.4 kcalmol-1. Pathway 4 leads to the β-keto ester stabilized anion 2.52 through the TS2.51,
which has a trans-fused 6,4-membered ring conformation. The preference for pathway 3 over
pathway 4 is evident, with a 13.2 kcalmol-1 difference in the activation barrier. However, both
pathway 3 and pathway 4 are unlikely because the activation barriers are too high in comparison
with the corresponding intramolecular proton transfer step of pathway 1 (∆E0 = 11.1 kcalmol-1)
and pathway 2 (∆E0 = 20.8 kcalmol-1). This is presumably associated with the highly strained,
four-membered ring transition state, though the transferred protons are much more acidic.
2.5 Conclusion
In summary, the one-carbon bridge stereochemistry of bicyclo[3.3.1]nonane systems
formed by Robinson annulations has been established, and factors influencing stereoselectivity
have been examined. For base-catalyzed reactions conducted under previously reported reaction
conditions, we found that the major diastereomer formed places the one-carbon bridge
substituent anti to the β-keto ester/amide unit introduced in the reaction, and stereoselectivity
appears to be kinetically controlled. Thermodynamically controlled stereoselectivity can be
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realized under more forcing conditions in the presence of a large excess of base through an
interesting epimerization reaction. In the case of one β-keto amide system that we have
investigated, it appears that it may be possible to use base catalyzed epimerization as a means to
reverse the kinetic selectivity obtained in these Robinson annulation reactions, thus obtaining the
syn diastereomer as the major product.
The

mechanism

of

the

base

catalyzed

Robinson

annulations

leading

to

bicyclo[3.3.1]nonanes has been studied with the aid of density functional theory calculations.
This mechanism study shows that the intramolecular proton transfer step is the rate determining
step, and that the pathway leading to the anti products is preferred, which is in agreement with
the experimental results. Furthermore, the intramolecular proton transfer process from the most
acidic proton of the β-keto ester group with a much higher activation barrier has been excluded.
In addition, solvent-assisted proton transfer process has little effect on stereoselectivity based on
the experimental results. This mechanism study could be a useful guide for future experimental
design to reverse the selectivity of the reaction.
2.6 Experimental
2.6.1 General Considerations
The preparation experiments were performed under a nitrogen atmosphere in ovenand/or flame-dried glassware using a Vacuum Atmospheres dry box or by using standard
Schlenk techniques. Solvents used as reaction media were distilled immediately before use:
acetonitrile, THF and ether were distilled from Na/benzophenone ketyl. NMR solvent (CDCl3)
was purchased from Cambridge Isotope Laboratories, Inc. All of the other reagents were
purchased from Sigma-Aldrich and used without any further purification.
1

H spectra was recorded on a Bruker AV-400 (400 MHz 1H) or a Bruker AC-250 (250

MHz 1H) spectrometer in deuterated solvents using the solvent residual protons or carbons as an
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internal reference (CDCl3: 7.26 ppm 1H for 1H NMR, CDCl3: 77.0 ppm, t for

13

C NMR).

Chemical shifts (δ) are given in parts per million down from tetramethylsilane (TMS). Data for
1

H NMR spectra are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d =

doublet, t = triplet, q = quartet, quin =quintet, dd = doublet of doublets, dt = doublet of triplets,
ddd = doublet of doublet of doublets, ddt = doublet of doublet of triplets, m = multiplet),
coupling constant (Hz), and integration. HRMS data were obtained using ESI ionization.
2.6.2 First Generation on Approach to Bicyclo[3.3.1]nonanes

A solution of 2-cyclohexenone (1 g, 0.01 mol) in 5 ml of anhydrous ether was added
dropwise to a cold (0oC) stirred suspension of LiAlH4 (10 ml LiAlH4 in Et2O solution, 1.0M) in
20 ml of anhydrous ether. After the addition was complete, the reaction mixture was stirred for
10 min, then slowly quenched with 4 ml of saturated Na2SO4 solution. Anhydrous MgSO4 was
added and the mixture was stirred for an additional 30 min, filtered and the solvent was
evaporated in vacuo to afford the crude product, which was then purified by column with DCM
as eluent furnished the allyl alcohol (0.93 g, 93%) as a pale yellow oil. 1H NMR (400 MHz,
CDCl3): δ 5.82-5.85 (m, 1H), 5.74-5.77 (m, 1H), 4.20 (s, 1H), 1.88-2.01 (m, 2H), 1.70-1.77 (m,
1H), 1.50-1.60 (m, 2H), 1.26 (s, 1H).

13

C NMR (100 MHz, CDCl3): δ 130.10, 130.04, 65.31,

31.88, 24.98, 19.04.

To a stirred solution of cyclohex-2-enol (0.2 g, 2.0 mmol) in 8 ml of CH2Cl2 at 0oC was
added m-CPBA (0.46 g, 77% max., 2.0 mmol) in 5 ml of CH2Cl2 dropwise. After stirring for 5
53

hours at 0oC, the reaction mixture was quenched by addition of saturated aqueous Na2S2O3 (2
ml) and stirred for 15 min at r.t. After addition of saturated aqueous NaHCO3 (5 ml), the mixture
was separated and the aqueous layer was extracted by CH2Cl2 thoroughly. The combined organic
layer was dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified
by flash chromatography (Hex/EA = 3:1~3:2) to give epoxide alcohol (0.19 g, 82%) as a
colorless oil. 1H NMR (400 MHz, CDCl3): δ 3.99-4.02 (m, 1H), 3.31-3.35 (m, 2H), 1.80-1.87 (m,
2H), 1.45-1.56 (m, 3H), 1.24-1.28 (m, 1H).

To a stirred suspension of copper (I) iodide (0.065 g, 0.34mmol) in 12 ml of anhydrous
ether under nitrogen at -8℃ was added allylmagnesium bromide in ether (1.0 M, 3.4 ml, 3.4
mmol). The black suspension was immediately cooled to -40 oC, and epoxide alcohol 2.05 (0.13
g, 1.1 mmol) in 1 ml of anhydrous ether was added slowly. The brown homogeneous solution
was then stirred at -40 oC for 4 hours and a 2:1 mixture (3 ml) of sat. aqueous NH4Cl and 28%
NH3·H2O was added. The organic layer was separated and the aqueous layer (blue color) was
extracted with CH2Cl2 (5  5 ml). The combined organic layer was dried over Na2SO4, filtered
and concentrated in vacuo to give the crude product, which is a 1,2- and 1,3-diol mixture. This
crude product was dissolved in THF (10 ml) and H2O (10 ml), and then NaIO4 (0.2 g) was added
at r.t. The resulting solution was stirred for 3 hours and then diluted with DCM (10 ml). After
separation of the organic phase, the water layer was thoroughly extracted by DCM and the
combined organic phases were dried over MgSO4, filtered and concentrated to give the aldehyde
and 1,3-diol mixture. The crude product was purified by flash chromatography (Hex/EA =
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5:1~1:3) to give epoxide alcohol 2.06 (0.09 g, 50%) as a colorless oil. 1H NMR (400 MHz,
CDCl3): δ 5.90-6.00 (m, 1H), 5.15 (d, J = 16 Hz, 1H), 5.07 (d, J = 8 Hz, 1H), 3.49-3.54 (m, 2H),
2.38-2.41 (m, 2H), 1.83-1.88 (m, 3H), 1.56-1.60 (m, 1H), 1.30-1.40 (m, 3H).

13

C NMR (100

MHz, CDCl3): δ 137.16, 116.61, 71.48, 50.02, 33.27, 21.02, 18.55.

To a solution of the diol 2.06 (3.9 g, 0.025 mol) in pyridine (35 ml) was added TsCl (16.66
g, 0.087 mol), and the reaction mixture was stirred at r.t. for 24 hours. The pyridine was removed
in vacuo and the residue was purified by flash chromatography (Hex/EA = 5:1) to give the
tosylate (9.9 g, 85%) as white solid. 1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 4H),
7.32 (d, J = 8.3 Hz, 4H), 5.45-5.50 (m, 1H), 4.97 (d, J = 10.2 Hz, 1H), 4.91 (d, J = 17.0 Hz, 1H),
4.36-4.42 (m, 2H), 2.44 (s, 6H), 2.12-2.13 (m, 2H), 1.97-1.98 (m, 2H), 1.70-1.86 (m, 2H), 1.411.45 (m, 2H), 1.22-1.25 (m, 2H).

13

C NMR (100 MHz, CDCl3): δ 144.69, 134.62, 132.89,

129.79, 127.62, 118.75, 80.27, 45.92, 30.92, 30.74, 21.61, 18.40.

To a stirred solution of the diol 2.06 (0.3 g, 1.9 mmol) and Et3N (1.2 ml, 8.8 mmol) in 3.2
ml of CH2Cl2 in an ice bath under nitrogen, was added dropwise MsCl (0.36 ml, 4.6 mmol). The
resulting solution was stirred for 1 hour at 0 oC, sat. NH4Cl was then added and the mixture was
extracted with CH2Cl2. The combined organic phases were washed with brine, dried (MgSO4)
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and concentrated to give the crude product, which was purified by flash chromatography
(Hex/EA = 1:1) to give the mesylate (0.52 g, 87%) as white solid. 1H NMR (400 MHz, CDCl3):
δ 5.83-5.87 (m, 1H), 5.18-5.23 (m, 2H), 4.52-4.58 (m, 2H), 3.04 (s, 6H), 2.38-2.40 (m, 2H),
2.19-2.24 (m, 2H), 2.00-2.04 (m, 1H), 1.80-1.84 (m, 1H), 1.62-1.65 (m, 3H).
2.6.3 General Procedure for the Robinson Annulations
To the freshly prepared sodium methoxide (1.1 eqiv.) in methanol (0.55 M) was added
ethyl acetoacetate or acetoacetamide or 3-oxobutanenitrile (1.1 eqiv.) and the enone substrate
(1.0 eqiv.) under nitrogen. The resulting solution was heated under reflux for 84 hours. The
mixture was cooled down to room temperature and then the methanol was removed under
vacuum. The concentrated mixture was neutralized by 3N HCl to pH = 6 and then extracted with
CH2Cl2. The organic layer was dried (MgSO4) and concentrated in vacuo led to crude product
which could be purified using column chromatography (SiO2).

Column chromatography (1:5 ethyl acetate:hexane) yielded the product as a pale yellow
oil (yield: 54%). The product was obtained as an inseparable mixture of diastereomers. 1H NMR
(400 MHz, CDCl3): δ 12.11 (s, 1H), 5.78-5.86 (m, 1H), 5.06-5.15 (m, 2H), 3.75 (s, 3H), 2.892.99 (m, 1H), 2.46-2.57 (m, 3H), 2.17-2.23 (m, 1H), 1.78-1.82 (m, 3H), 1.52-1.69 (m, 4H), 1.221.28 (m, 1H).
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C NMR (100 MHz, CDCl3): δ 171.75, 171.71, 137.54, 116.10, 101.38, 70.55,

51.36, 45.82, 45.34, 35.14, 32.03, 30.07, 21.79, 18.61. Some of the characteristic peaks of the
minor component: 1H NMR (400 MHz, CDCl3): δ 12.17 (s). HRMS (ESI): m/z calcd. for
(C14H20O4+Na+): 275.1254; found: 275.1256.
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Diastereomers 2.21a and 2.21b (total yield: 42%) were separated by column
chromatography (7:1 hexane:ethyl acetate). The major diastereomer 2.21b was a crystalline solid
that could be further purified by recrystallization from petroleum ether.
2.21a: 1H NMR (400 MHz, CDCl3): δ 12.14 (s, 1H), 5.76-5.87 (m, 1H), 4.97-5.05(m,
2H), 3.76 (s, 3H), 2.94-2.95 (m, 1H), 2.33-2.50 (m, 4H), 2.00-2.18 (m, 1H), 1.79-1.82 (m, 2H),
1.56-1.65(m, 3H), 0.98-1.28 (m, 3H), 0.88 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
172.38, 171.69, 137.73, 116.18, 97.95, 71.36, 51.78, 51.52, 47.59, 40.41, 39.05, 33.84, 31.43,
25.96, 21.48. HRMS (ESI): m/z calcd. for (C15H22O4+H+): 267.1591; found: 267.1586.
2.21b: 1H NMR (400 MHz, CDCl3): δ 12.06 (s, 1H), 5.78-5.84 (m, 1H), 5.11 (d, J =
17Hz, 1H), 5.06 (d, J = 10Hz, 1H), 3.75 (s, 3H), 2.87 (s, 1H), 2.50-2.55 (m, 3H), 2.08-2.16 (m,
1H), 1.76-1.79 (m, 1H), 1.62-1.68 (m, 2H), 1.51-1.55 (m, 1H), 1.32-1.38 (m, 2H), 1.18-1.22 (m,
1H), 0.90 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 171.72, 171.45, 137.57, 116.28,
102.24, 71.32, 51.47, 46.02, 45.02, 44.36, 32.44, 31.15, 30.34, 25.29, 21.70. HRMS (ESI): m/z
calcd. for (C15H22O4+H+): 267.1591; found: 267.1592.
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Diastereomers 2.23a and 2.23b (total yield: 31%) were separated by column
chromatography (7:1 hexane:EtOAc). The major diastereomer 2.23b was a crystalline solid that
could be further purified by recrystallization from petroleum ether.
2.23a: 1H NMR (400 MHz, CDCl3): δ 12.11 (s, 1H), 5.71-5.76 (m, 1H), 4.90-4.94 (m,
2H), 3.68 (s, 3H), 2.89-2.92 (m, 1H), 2.44-2.48 (m, 2H), 2.15-2.42 (m, 2H), 1.70-1.83 (m, 2H),
1.42-1.52(m, 4H), 1.20-1.33 (m, 2H), 0.92 (d, J = 6.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
172.41, 171.81, 137.89, 115.96, 96.97, 73.02, 51.42, 49.03, 44.25, 33.85, 31.52, 30.44, 28.31,
24.62, 14.88. HRMS (ESI): m/z calcd. for (C15H22O4+H+): 267.1591; found: 267.1588.
2.23b: 1H NMR (400 MHz, CDCl3): δ 12.09 (s, 1H), 5.76-5.83 (m, 1H), 5.10 (d, J = 16
Hz, 1H), 5.07 (d, J = 7.8 Hz, 1H), 3.73 (s, 3H), 2.87-2.88 (m, 1H), 2.69-2.75 (m, 1H), 2.49-2.54
(m, 1H), 2.15-2.24 (m, 2H), 1.79-1.84 (m, 2H), 1.61-1.66 (m, 2H), 1.44-1.48 (m, 1H), 1.24-1.27
(m, 1H), 1.13-1.23 (m, 1H), 0.93 (d, J = 6.6 Hz, 3H).
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C NMR (100 MHz, CDCl3): δ 171.78,

171.52, 137.74, 116.25, 101.32, 72.83, 51.42, 46.52, 39.13, 35.94, 32.48, 30.01, 27.70, 23.33,
14.85. HRMS (ESI): m/z calcd. for (C15H22O4+Na+): 289.1410; found: 289.1416.

Column chromatography (1:3~1:1 ethyl acetate:hexane) yielded the product as a colorless
oil (yield: 43%). The product was obtained as an inseparable mixture of diastereomers. 1H NMR
(400 MHz, CDCl3): δ 12.03 (s, 1H), 3.87 ( br s., 2H), 3.68 (s, 3H), 3.54-3.60 (m, 2H), 2.80-2.81
(m, 1H), 2.40-2.52 (m, 2H), 1.60-1.88 (m, 4H), 1.34-1.45 (m, 6H), 1.17 (d, J = 12 Hz, 1H). 13C
NMR (100 MHz, CDCl3): δ 171.91, 171.74, 101.37, 70.68, 61.96, 51.41, 45.79, 45.05, 34.87,
32.40, 30.56, 22.02, 21.22, 18.54. Some of the characteristic peaks of the minor component: 1H
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NMR (400 MHz, CDCl3): δ 12.09 (s). HRMS (ESI): m/z calcd. for (C14H22O5+H+): 271.1540;
found: 271.1541.

Diastereomers 2.26a and 2.26b (total yield: 56%) were separated by column
chromatography (6:1 hexane:EtOAc). The major diastereomer 2.26b was a crystalline solid that
could be further purified by recrystallization from petroleum ether.
2.26a: 1H NMR (400 MHz, CDCl3): δ 12.14 (s, 1H), 4.70 (s, 1H), 4.68 (s, 1H), 3.76 (s,
3H), 2.87-2.88 (m, 1H), 2.53-2.55 (m, 1H), 2.48-2.49 (m, 1H), 2.33-2.37 (m, 1H), 1.84-1.89 (m,
1H), 1.68-1.83 (m, 6H), 1.24-1.42 (m, 2H), 0.96 (d, J = 6.8 Hz, 3H).

13

C NMR (100 MHz,

CDCl3): δ 172.37, 171.70, 148.34, 109.27, 97.80, 71.34, 51.53, 47.61, 42.30, 39.79, 38.23, 37.20,
35.43, 21.03, 12.92. HRMS (ESI): m/z calcd. for (C15H22O4+H+): 267.1591; found: 267.1594.
2.26b: 1H NMR (400 MHz, CDCl3): δ 12.06 (s, 1H), 4.70 (s, 2H), 3.75 (s, 3H), 2.83-2.84
(m, 1H), 2.56 (s, 2H), 2.12-2.19 (m, 1H), 1.89-1.90 (m, 1H), 1.51-1.67 (m, 7H), 1.38-1.41 (m,
1H), 1.09 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 171.72, 171.60, 148.50, 109.24,
102.20, 71.20, 51.50, 45.64, 39.84, 39.59, 37.60, 35.84, 27.40, 20.97, 11.90. HRMS (ESI): m/z
calcd. for (C15H22O4+H+): 267.1591; found: 267.1593.
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Diastereomers 2.31a and 2.31b (total yield: 80%) were separated by column
chromatography (2:1~1:1 hexane:EtOAc). The major diastereomer 2.31b was obtained as a
crystalline solid.
2.31a : 1H NMR (400 MHz, CDCl3): δ 14.15 (s, 1H), 5.46 (s, 2H), 4.73 (s, 1H), 4.70 (s,
1H), 2.50-2.55 (m, 2H), 2.23-2.38 (m, 2H), 1.88-1.91 (m, 1H), 1.70-1.78 (m, 6H), 1.38-1.53 (m,
3H), 1.24-1.28 (m, 1H), 1.01 (d, J = 6.8 Hz, 3H).

13

C NMR (100 MHz, CDCl3): δ 173.95,

171.85, 147.94, 109.56, 96.75, 71.12, 47.40, 42.58, 40.11, 38.66, 38.27, 35.30, 21.04, 13.05.
HRMS (ESI): m/z calcd. for (C14H21NO3+H+): 252.1594; found: 252.1602.
2.31b: 1H NMR (400 MHz, CDCl3): δ 14.08 (s, 1H), 5.54 (s, 2H), 4.73 (s, 1H), 4.71 (s,
1H), 2.47-2.57 (m, 2H), 2.20-2.24 (m, 1H), 1.78-1.98 (m, 1H), 1.57-1.70 (m, 7H), 1.19-1.43 (m,
3H), 1.12 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 173.22, 171.82, 148.11, 109.51,
101.27, 70.94, 45.97, 40.07, 39.41, 37.63, 37.32, 27.41, 20.98, 12.14. HRMS (ESI): m/z calcd.
for (C14H21NO3+Na+): 274.1414; found: 274.1415.

Column chromatography (1:2~1:1 ethyl acetate:hexane) yielded the product as a pale
yellow oil (yield: 54%). The product was obtained as an inseparable mixture of diastereomers.
1

H NMR (400 MHz, CDCl3): δ 4.81 (s, 1H), 4.76 (s, 1H), 2.43-2.54 (m, 6H), 2.35-2.38 (m, 1H),

1.70-1.77 (m, 5H), 1.19-1.26 (m, 1H), 1.11 (d, J = 6.5 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
209.26, 198.18, 146.10, 115.51, 110.80, 48.41, 46.80, 46.21, 43.86, 43.24, 32.58, 29.40, 20.12,
11.29. Some characteristic peaks of the minor component: 1H NMR (400 MHz, CDCl3): δ 0.95
(d, J = 6.5 Hz). HRMS (ESI): m/z calcd. for (C14H19NO2+Na+): 256.1308; found: 256.1320.
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2.6.4 Preparation of Compounds 2.28a and 2.28b

To the freshly prepared sodium methoxide (0.036 g Na, 1.56 mmol) in 2.0 ml of MeOH
was added compound 2.12 (0.36 g, 1.40 mmol) in MeOH (0.8 ml) and then MeI (0.26 ml, 4.24
mmol). The resulting solution was stirred at r.t. overnight and then the MeOH was removed.
Ethyl acetate and water were added to the residue and the organic layer was separated. The water
phase was extracted with ethyl acetate. The combined organic phase was washed with brine,
dried (MgSO4), filtered and concentrated to give the product 2.27 (0.38 g, quant.) as a pale
yellow oil, which is pure enough for the next step. 1H NMR (400 MHz, CDCl3): δ 5.76-5.82 (m,
1H), 4.97-5.15 (m, 2H), 3.72 (s, 3H), 2.51-2.68 (m, 3H), 2.18-2.22 (m, 2H), 1.74-1.79 (m, 2H),
1.49-1.63 (m, 6H), 1.33-1.45 (m, 1H), 1.22-1.27(m, 2H).

13

C NMR (62.5 MHz, CDCl3): δ

207.58, 172.24, 136.56, 116.71, 71.72, 60.28, 59.32, 53.41, 51.87, 42.25, 41.60, 34.30, 30.20,
23.40, 22.04, 19.03, 14.01. Some of the characteristic peaks of the minor component: 13C NMR
(62.5 MHz, CDCl3): δ 206.37, 171.80, 137.53, 115.97. HRMS (ESI): m/z calcd. for
(C15H22O4+Na+): 289.1410; found: 289.1417.
To a solution of the substrate 2.27 (6.826 g, 0.026 mol) in 26 ml of MeOH was added 26
ml of 3.0 M aqueous KOH (0.078 mol). The solution was refluxed for 24 hours. After cooled
down to r.t., the methanol in the solution was removed in vacuo. The resulting water phase was
acidified to pH 0 and stirred for five minutes, and then extracted with DCM. The organic layer
was dried (MgSO4), filtered and concentrated. Column chromatography (Hex/EA = 3:1) yielded
the product 2.28a and 2.28b (4.80 g, ratio=1:1, total yield: 90%) as colorless oil.
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1

H NMR (400 MHz, CDCl3): δ 5.76-5.86 (m, 1H), 5.03-5.10 (m, 2H), 2.74-2.78 (m, 1H),

2.58-2.62 (m, 1H), 2.38-2.42 (m, 2H), 2.07-2.18 (m, 3H), 1.76-1.86 (m, 3H), 1.52-1.60 (m, 2H),
1.21-1.34 (m, 2H), 1.08-1.19 (m, 1H), 1.02 (d, J = 6.7 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
212.09, 137.19, 116.51, 73.67, 50.49, 48.41, 42.62, 41.00, 38.94, 31.11, 27.27, 20.07, 11.82.
HRMS (ESI): m/z calcd. for (C13H20O2+H+): 209.1536; found: 209.1533.

1

H NMR (400 MHz, CDCl3): δ 5.78-5.88 (m, 1H), 5.05-5.13 (m, 2H), 2.58-2.66 (m, 2H),

2.34-2.54 (m, 3H), 2.12-2.23 (m, 2H), 1.95-2.04 (m, 2H), 1.70-1.79 (m, 1H), 1.63-1.66 (m, 1H),
1.46-1.52 (m, 4H), 1.06 (d, J = 6.8 Hz, 3H).

13

C NMR (100 MHz, CDCl3): δ 211.94, 137.43,

116.44, 73.13, 56.38, 49.07, 48.47, 39.06, 34.63, 30.85, 19.38, 18.70, 12.12. HRMS (ESI): m/z
calcd. for (C13H20O2+Na+): 231.1356; found: 231.1351.
2.6.5 General Procedure for Thermodynamic Control Reaction
To a solution of the substrate (1 equiv.) in MeOH (1M) was added the equal volume of x
M aqueous KOH (x eqiv., for the corresponding equiv., see the thesis). The solution was refluxed
for 24 hours. After cooled down to r.t., the methanol in the solution was removed in vacuo. The
resulting water phase was acidified to pH = 0 and stirred for a few minutes, and then extracted
with DCM (for substrate 2.31, using chloroform to extract and added a little bit MeOH to the
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combined organic phases). The organic layer was dried (MgSO4), filtered and concentrated to
afford the crude product, which could be purified using column chromatography (SiO2).
2.6.6 General Computational Consideration
All calculations were carried out with DFT method as implemented in GAUSSIAN 03.[19]
All structures were optimized by the B3LYP/6-31G(d) method. The stationary points were
characterized by harmonic analysis. For all the transition structures, the vibration related to the
imaginary frequency corresponds to the nuclear motion along the reaction coordinate. Intrinsic
reaction coordinate (IRC) calculations were performed to ensure that the transition structures
connect related intermediates correctly. Unless specifically mentioned, the discussed Gibbs free
energy (ΔG), the enthalpy (ΔH), and the zero-point corrected energy (ΔE0) were computed at
298 K in the gas phase by using the B3LYP/6-31G(d) method.
2.6.7 Spectral Data
Spectral data are shown from the next page.
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CHAPTER 3 AN APPROACH TO THE SYNTHESIS OF VINIGROL VIA TWOCARBON RING EXPANSION STRATEGY
3.1 Background and Significance
The diterpenoid vinigrol (3.01) was isolated in 1987 from fungal strain Virgaria nigra F5408 by Hashimoto and co-workers.[1] An evaluation of the biological activity of vinigrol shows
antihypertensive and platelet aggregation-inhibiting properties.[1b, 1c] Furthermore, vinigrol has
shown to function as a potential tumor necrosis factor (TNF) antagonist agent,[2] and could
therefore be useful for the treatment of inflammation and a host of autoimmune disease
responses. Moreover, TNF antagonists are thought to slow the progression of AIDS, and are
therefore considered especially valuable.[3]
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Scheme 3.1 Proposed Biosynthesis of Vinigrol
It has been proposed by Corey that vinigrol arises biosynthetically from the common
diterpene building block geranylgeranyl pyrophosphate (3.02) following the sequence shown in
Scheme 3.1.[4] The pyrophosphate 3.02 is believed to undergo an enzyme-assisted cyclization to
arrive at the ten-membered ring intermediate 3.03. Subsequent [1,3]-hydride shift and cyclization
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yield compound 3.04, which is oxidized to provide phenol derivative 3.05. Oxidative cyclization
of 3.05 installs the final ring and provides tricycle 3.06.[5] Additional oxidation state adjustments
of tricycle 3.06 ultimately give rise to 3.01.

Figure 3.1 Historically Challenging Carbogenic Ring Systems in Terpene Synthesis

Scheme 3.2 Views of Vinigrol (3.01)
From a chemical standpoint, the provocative structure of vinigrol features an
unprecedented decahydro-1,5-butanonaphthalene carbon skeleton that is not found in any other
natural product. As such, it holds a special place alongside other historically challenging
diterpene systems, such as the ingenanes, taxanes, and phomactins (see Figure 3.1).[6] Although
3.01 is relatively small in size (molecular weight < 325 Da), the presence of eight contiguous
stereocenters and multiple sites of oxygenation make it a particularly challenging synthetic
problem, which can be analyzed from several seemingly different topological viewpoints
(Scheme 3.2). Due to the promising biological properties of vinigrol and its unique terpene
framework, innovative strategies toward the total synthesis of vinigrol are being pursued by at
least ten organic research groups.[4, 7] Over the past 24 years, more than 20 papers, six doctoral
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dissertations and three reviews[8] describing synthetic efforts toward vinigrol have been
published, including four syntheses capable of preparing the skeleton of vinigrol, and one
completed total synthesis. Each approach is presented in detail in the following sections.
3.2 Previous Synthetic Approaches to Vinigrol
3.2.1 Paquette’s Attempt Based on a cis-Decalin Framework

Scheme 3.3 Inherent Challenge of Building the Ring System of Vinigrol from a cisDecalin
Paquette et al. have published efforts toward the synthesis of vinigrol.[7l,

7o-q]

Their

continuous efforts have vividly demonstrated the difficulty in forming the bridging eightmembered ring of vinigrol from a pre-existing cis-decalin framework (3.07 to 3.08). A variety of
approaches (Scheme 3.3), including intramolecular alkylation, Ring-Closing Metathesis,
incorporating a lactone bridge as a conformational lock, ring-contraction, etc., have been
explored without success. Their calculations on related model compounds point to a largely
unfavorable equilibrium between two conformers (ΔE ≈ 12.5 kcalmol-1), with the major
conformer (3.09a) lacking the proximity needed for ring closure.
3.2.2 Hanna’s Approach toward Vinigrol
Hanna’s group reported the most advanced vinigrol intermediate so far.[7a, 7c, 7f, 7k, 7ab] Their
strategy centered on an oxy-Cope rearrangement to provide the tricyclic core of vinigrol. As
shown in Scheme 3.4, their synthesis commenced with the readily available silyl enol ether 3.10,
which was transformed to the mixed trimethylsilyl ketal 3.11 in three steps. The alcohol 3.11 was
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Scheme 3.4 Hanna’s Approach to Vinigrol
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submitted to Mitsunobu inversion, followed by cleavage of the resulting ester to yield 3.12.
Silylation of the alcohol 3.12 and subjection to standard radical-generating conditions followed
by Tamao oxidation furnished the diol 3.13. Protection of the diol with 2,2-dimethoxypropane
followed by dehydration delivered the key tricyclic ketone 3.14.
Next, the ketone 3.14 was treated with Grignard reagent to form a separable mixture of
endo and exo alcohols. Chemoselective reduction of the triple bond afforded the oxy-Cope
precursor 3.15, which was readily converted to the tricyclic skeleton 3.16 with the desired
stereocenters after oxy-Cope reaction and hydrogenation. The tricyclic ketone 3.16 was then
exposed to osmium tetroxide and LiAlH4, furnishing the triol 3.17. Treatment of the triol 3.17
with triphosgene led to the cyclic carbamate 3.18. Next, the carbamate 3.18 was hydrogenated to
give an inseparable mixture of 3.19, which was protected by 2,2-dimethoxypropane to afford a
2:1 separable mixture of 3.20. Hydrolysis of the cyclic carbamate 3.20 followed by elimination
gave a mixture of five products which were separated by careful column chromatography on
silica gel to afford the alkene 3.21. Finally, hydrogenation and deprotection afforded the triol
3.22, which is an epi-C-8-dihydrovinigrol.
3.2.3 Corey’s Attempt toward Vinigrol

Scheme 3.5 Corey’s Attempt to Vinigrol
The Corey group aimed to assemble the tricyclic core by a late stage intramolecular DielsAlder reaction (Scheme 3.5).[4] To this end, (R)-limonene (3.23) was elaborated to triene 3.24
109

over seven steps. However, the final Diels-Alder cycloaddition has remained elusive under
various conditions and modifications on the triene.
3.2.4 Barriault’s Approach toward Vinigrol

Scheme 3.6 Barriault’s Approach to Vinigrol
An alternative Diels-Alder disconnection was devised by Barriault et al. in 2007, though
their previous synthesis based on other strategies was unsuccessful.[7m, 7n, 7r, 7s, 8a] Their strategy
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was to build up the tricyclic core by planning the Diels-Alder reaction earlier in the anticipated
sequence.
Their approach began with the known aldehyde 3.26, which was transformed to the vinyl
iodide 3.27 by a Takai olefination. Subsequent Buchwald’s copper(I)-mediated coupling of 3.27
with the allylic alcohol led to the enol ether 3.28. Treatment of the vinyl allyl ether 3.28 with
triisobutylaluminum effected both the Claisen rearrangement and the reduction in a single step,
affording the hydroxyalkene, which was further protected to give the siloxy ether 3.29. Next, a
three step functional manipulation and removal of the silyl ether delivered the alcohol 3.31. A
TPAP oxidation followed by a modified version of Ohira’s protocol led to the alkyne 3.32 as the
sole diastereomer in 54% yield over two steps. Conversion of 3.32 to 3.33 was performed via
DDQ removal of the PMB group, TPAP oxidation of the resulting alcohol, and Wittig olefination
under Conia conditions.
Then, the enyne metathesis was effected by Grubb’s 2nd generation catalyst followed by
reduction of the nitrile group to yield 3.34. The enone 3.35 was obtained by a three-step
functional manipulation. Finally, the intramolecular Diels-Alder reaction took place smoothly to
gave the cycloadduct 3.36 when the triene 3.35 was treated with BF3·OEt2 in dichloromethane at
-78oC.
3.2.5 Fallis’s Approach toward Vinigrol
Fallis’s group successfully prepared the skeleton of vinigrol based on a similar
intramolecular Diels-Alder reaction.[7t] Their synthesis commenced with the homoallylic crossconjugated trieneol 3.37, which could be readily prepared from 1,3-propanediol in six steps. A
Lewis acid catalyzed and self-assembled Diels-Alder reaction from the trieneol 3.37 with Nmethylmaleimide afforded the monoadduct 3.38 with diastereo-, regio-, and chemoselective
control. Further manipulations of 3.38 led to the enone 3.39. The cyclization of the Diels-Alder
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precursor 3.39 was particularly facile, and no added catalyst was required. On a preparative
scale, heating 3.39 in deuterochloroform provided quantitative conversion to the tricyclic core of
vinigrol, 3.40.

Scheme 3.7 Fallis’s Approach to Vinigrol
3.2.6 Njardarson’s Approach toward Vinigrol
Njardarson’s group recently reported a highly expedient and convergent synthetic
approach toward the total synthesis of vinigrol.[7w-y] They prepared the core of vinigrol from
commercially available ketone 3.42 in only four steps. The key features involve an oxidative
dearomatization/Diels-Alder reaction sequence between allylic alcohol 3.41 and phenol 3.42 in
the presence of iodobenzene bis(trifluoroacetate) to furnish the cycloadduct 3.43. Then, a radical
cyclization took place under standard conditions to form the exo-ketone 3.44, which was
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successfully bis-olefinated using the Peterson olefination protocol to afford the tetraene 3.45.
Finally, despite significant steric hindrance, the tetraene 3.45 could be cyclized using the
Grubbs-Hoveyda catalyst 3.46 in the presence of benzoquinone to deliver the pentacyclic
compound 3.47, which is close to the core structure of vinigrol (see Scheme 3.2 to compare the
structure of 3.47 and vinigrol).

Scheme 3.8 Njardarson’s Approach to Vinigrol
3.2.7 Baran’s Total Synthesis of Vinigrol
In 2008, Baran’s group reported a very concise (9 steps), high-yield route (20% overall
yield) to the skeleton of vinigrol based on an inter- and intramolecular Diels-Alder reactions
followed by Grob fragmentation[7u]. They are able to apply this concise route to the total
synthesis of vinigrol later by a 23-step route in 3% overall yield.[7z, 7aa] This study remains the
only completed total synthesis of vinigrol to date.
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Scheme 3.9 Baran’s Total Synthesis of Vinigrol
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Their synthesis commenced with the commercially available diene 3.48 and (E)-methyl 4methyl-2-pentenoate, which were converted to the bicyclic ketone 3.49 via an endo-selective
Diels-Alder reaction. Triflation of 3.49 and subsequent Stille coupling formed requisite diene
3.50 in 78% yield. After an oxidation state adjustment, allyl magnesium bromide was added to
the corresponding aldehyde (d.r. = 6:1) 3.51 producing an intermediate alkoxide 3.52, which was
directly heated to 105 °C to initiate the intramolecular Diels-Alder reaction followed by aqueous
workup to furnish tetracycle 3.53. Next, the alcohol 3.53 was oxidized by DMP to give ketone
3.54, an intermediate available in decagram quantities in seven steps from commercially
available materials. The C-9 methyl group was installed by alkylation (LDA, MeI), and,
following silyl group removal (TBAF), the adjacent alcohol stereochemistry was established
using Evans’s Me4NBH(OAc)3-mediated, hydroxyl-directed reduction to deliver 3.55 as a single
diastereomer in 72% yield over the three-step sequence. Next, mesylation of 3.55 and treatment
with KHMDS smoothly afforded the vinigrol core structure 3.56 via a mild Grob fragmentation.
Their next target focused on the installation of the C-8 methyl and C-8a hydroxyl group,
which proved to be challenging due to the cis orientation. A dipolar [3+2] cycloaddition was
effected by exposure of 3.56 to bromonitrile oxide, which was generated in situ from
dibromoformaldoxime and KHCO3, leading to the formation of 3.57 as a single isomer both
chemo- and stereoselectively. Ketone reduction with DIBAL followed by directed olefin
hydrogenation furnished 3.58. Xanthate formation and subsequent Chugaev elimination afforded
olefin 3.59 in 85% overall yield (4 steps from 3.57). Then, the desired tertiary alcohol 3.61 was
obtained by unveiling the bromoisoxazole 3.59 by the Saegusa deamination sequence: (1)
reduction with LAH and immediate formylation of the crude amine 3.60, (2) dehydration to a
primary isonitrile, and (3) reduction with Bu3SnH in the presence of AIBN in 56% overall yield.
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In the final stage, dihydroxylation of 3.61 with OsO4 and chemoselective oxidation of the
resulting diol gave α-hydroxy ketone 3.62 in 81% overall yield. Finally, a Shapiro reaction took
place by treatment of the trisylhydrazone 3.63 with

n

BuLi and TMEDA followed by

formaldehyde to deliver vinigrol, presumably through the trianionic species 3.64.
3.3 Retrosynthetic Analysis

Figure 3.2 Retrosynthetic Analysis Enlightened by the X-ray Crystal Structure
As can be seen from the crystal structure of the oxidized product of vinigrol (3.65)[1a],
there seems to be a four-membered ring within the bridging eight-membered ring (Figure 3.2).
Enlightened by this ‘four-membered ring’, we proposed preparing vinigrol from its sixmembered ring analogue 3.66 centered upon a two-carbon ring expansion strategy.
In order to avoid the cis-decalin framework in approaching the bridging eight-membered
ring of vinigrol, we envisioned that the bridging eight-membered ring could be constructed by
another easily accessed tricyclic compound, 3.69 or 3.72, based on a two-carbon ring expansion
strategy (Scheme 3.10). There are two possible pathways in applying this strategy. In path A, the
tricyclic adduct 3.67 could be prepared from enol ether 3.69 by a [2+2] cycloaddition with
dichloroketene followed by a retro-aldol reaction. In path B, the 1,4-dicarbonyl tricyclic 3.70
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could be obtained by an oxidative cleavage of the cyclobutene 3.71, which could in turn be
accessed from the conjugated diene 3.72 via electrocyclic reaction. Both the tricyclic 3.69 and
3.72 could be constructed by an intramolecular alkylation of the bicyclo[3.3.1]nonane 3.73.
According to Baldwin, such a 6-exo-tet cyclization should prove favorable.[9] The advantage of
this retrosynthetic plan is that we have two possible pathways to build vinigrol, and both
pathways result in the same starting material.

Scheme 3.10 Retrosynthetic Analysis of Vinigrol (3.01)
3.4 Gram Scale Synthesis of the Tricyclic Precursor of Vinigrol
3.4.1 First Generation Approach to the Tricyclic Precursor
Following known procedure,[10] enone 3.74 was prepared in three consecutive steps by
masking the double bond of 2-cyclohexenone (Scheme 3.11). As described in Chapter 2, the
bicyclo[3.3.1]nonane 3.75 was readily assembled as an inseparable diastereomeric mixture from
3.74 by a Robinson annulation. Methylation of 3.75 afforded bicyclic ketone 3.76 in quantitative
yield.
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Scheme 3.11 Synthesis of the [3.3.1] Ring System

Scheme 3.12 The Easily Enolizable Carbonyl Group
The carbonyl group of bicyclic ketone 3.76 was found to be extremely enolizable.
Protection of the tertiary hydroxy group of 3.76 by excess benzyl bromide in the presence of
sodium hydride and TBAI in THF did not afford the desired benzyl ether 3.78. The benzyl enol
ether 3.79 was formed instead (Scheme 3.12). A similar problem was encountered with siloxyl
ether protection. If 3.76 was treated with little excess (1.2 eq.) of TBSOTf, the doubly protected
compound 3.77 was formed as the major product (42%, Scheme 3.12). In comparison, when 3.76
was treated with large excess (2.2 eq.) of TBSOTf, 3.77 was formed as the sole product in good
yield (Scheme 3.11).
Next, chemoselective hydroboration of the allyl double bond of 3.77 followed by oxidation
produced the alcohol 3.81 (Scheme 3.13). Then, mesylation of the alcohol 3.81 with MsCl in
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dichloromethane followed by chemoselective removal of the enol ether TBS group furnished
mesylate 3.83. Having mesylate 3.83 in hand, we turned our attention to the intramolecular
alkylation. Unfortunately, our preliminary attempts at the preparation of the tricyclic 3.84 were
fruitless, even though various reaction conditions were explored. Although the mesylate 3.83
was a mixture of diastereomers with the unreactive isomer as the major component, some
cyclization product was expected. The ketone mesylate 3.83 was recovered upon treatment with
milder bases, while decomposed products were detected upon treatment with harsher bases. The
reluctance of this ring closure may be due to the strain energy associated with 1,3-diaxial
repulsion.

Scheme 3.13 Initial Efforts toward the Synthesis of the Tricyclic System
3.4.2 Revised Approach to the Tricyclic Precursor
Bearing in mind the severe 1,3-diaxial repulsion, it was considered a wise decision to
remove the extra methyl ester group in an earlier step in the modified synthesis (Scheme 3.14).
As described in Chapter 2, decarboxylation of 3.76 with large excess aqueous KOH gave the
epimerized product 3.85 as a diastereomeric mixture of 1:1 ratio. As in previous studies, TBS
protection, hydroboration-oxidation and chemoselective removal of the enol ether TBS group
offered us the primary alcohol 3.87 (Scheme 3.14).
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Scheme 3.14 Synthesis of the Tricyclic Precursor
In an effort to explore the role of protective groups in the synthesis of the tricyclic
compound, the MOM ether 3.88 was obtained by mixing the ketone alcohol 3.85 with MOMCl
in the presence of DIEA (Scheme 3.14). Next, chemoselective hydroboration-oxidation of the
allyl double bond was achieved to furnish the primary alcohol 3.89 in 97% yield by treating
MOM ether 3.88 with dicyclohexylborane followed by oxidative workup.[11] It is worth noting
that the borane reagent is crucial to achieve excellent selectivity. Both 9-BBN and BH3 react
preferentially with the carbonyl group of 3.88.

Scheme 3.15 The Intramolecular Alkylation
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Next, mesylation of the alcohol 3.87 produced mesylate 3.90, which was treated with
potassium tert-butoxide to afford the undesired regio-isomeric tricyclic 3.92 as the sole product
(Scheme 3.15). In an effort to perform the intramolecular alkylation, we decided to convert the
primary alcohol 3.87 to iodide, which would act as a better leaving group. Iodinization of the
alcohol afforded the iodide 3.91. To our surprise, when iodide 3.91 was exposed to potassium
tert-butoxide, the same tricyclic 3.92 was detected. These results indicate that only the
thermodynamic enolate can be formed using tBuOK as the base.
Table 3.1 Regioisomer Distribution in the Cyclization Reaction

a
b

Entry

Substrate

Base

Temperature

Ratioa

Total yieldb

1

3.91

LDA

-78oC

N.A.

No Reaction

2

3.91

LDA

-40 oC

2.3:1

100%

3

3.91

LDA

0 oC

2.0:1

75%

4

3.91

LiTMP

-40 oC

N.A.

No Reaction

5

3.91

LiTMP

-15 oC

3.8:1

100%

6

3.91

LiTMP

0o C

3.5:1

77%

7

3.93

LDA

0 oC

1.5 : 1

90%

The ratio of the two regioisomeric products is based on the 1H NMR of crude product
This is the yield of the two regioisomeric products based on the reactive substrate

This cyclization reaction was carefully studied. In order to obtain the desired tricyclic, we
tried LDA, a kinetically faster base at low temperature. Surprisingly, no reaction was detected w121

Figure 3.3 ORTEP Plot of Tricyclic Precursor 3.94
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Scheme 3.16 Synthesis of the Tricyclic Precursor of Vinigrol (3.01)
hen iodide 3.91 was treated with LDA at -78oC (Table 3.1, entry 1). Gratefully, the desired
tricyclic 3.94 was formed as the major product (ratio = 2.3:1) when the reaction temperature was
increased to -40oC (entry 2). And we were able to isolate the two regioisomeric products 3.92,
3.94 and the unreactive starting material 3.91b. As expected, the ratio dropped as the temperature
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increased. At 0 oC, both the ratio and the yield were reduced (entry 3). The optimized condition
was to use the more hindered base LiTMP and maintain the reaction temperature at -15 oC (entry
5). Substrate MOM ether 3.93 showed poorer selectivity in comparison with TBS ether 3.91
(entry 7).
It is worth noting that no reaction occurred when 3.91 was treated with LiTMP at -40oC
(entry 4), whereas the reaction was finished in one hour at the same temperature using LDA.
This result indicates that the formation of enolate rather than the alkylation step is the rate
determining step.
In summary, efforts toward the synthesis of the unusual tricyclic precursor of vinigrol
(3.01) are described. More than one gram of this tricyclic 3.94 has been successfully prepared
(Scheme 3.16), and the structure has been unambiguously assigned according to its crystal
structure (Figure 3.3). A Robinson annulation and an intramolecular alkylation allow the rapid
construction of the core ring system in eight steps (based on TBS protection) with an average
yield of 78%, and seven steps (based on MOM protection) with an average yield of 70%,
respectively (Scheme 3.16). This route is a potential approach to the synthesis of vinigrol.
3.5 A Potential Synthesis of the Tricyclic Precursor
3.5.1 De Mayo Photoannulations

Scheme 3.17 Seto’s Synthesis of Tricyclic Compound Using De Mayo Photoannulations
During Seto’s synthesis of the bicyclo[5.4.0]undecanes,[12] the tricyclic 3.97 was prepared
by De Mayo photoannulations (enone [2+2] photocycloaddition followed by a Grob
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fragmentation, Scheme 3.17).[13] Enlightened by this sequence, we designed a potential concise
route to our tricyclic intermediate 3.101 as outlined in Scheme 3.18.

Scheme 3.18 A Potential Approach to the Tricyclic Precursor

Scheme 3.19 Synthesis of the Photoannulation Precursor
When 3.98a is irradiated by UV light, an intramolecular [2+2] cycloaddition takes place
within 3.98 to yield 3.99 with both high regio- and stereo-control. Under basic conditions, the
acetate of 3.99 will be hydrolyzed followed by a retro-aldol to form the intermediate 3.100. After
proton transfer process, an aldol reaction will occur leading to the target tricyclic 3.101.
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As shown in Scheme 3.19, acid chloride 3.102 was readily prepared from 5-hexenoic acid,
which had been synthesized from cyclohexanone following a known procedure.[14] Then, 1morpholinocyclohexene was coupled with the acid chloride 3.102 to afford the diketone 3.103 by
standard procedure. Treatment of ketone 3.103 with acetyl chloride in the presence of pyridine
led to the acetate enol ether mixture 3.98a and 3.98b. 1H NMR indicated a 10:1 ratio of the two
regioisomers (major component undetermined). Similarly, a mixture of the TBS enol ether
3.104a and 3.104b (ratio = 3.6:1, indicated by 1H NMR and major component undetermined)
were obtained by treating ketone 3.103 with TBSOTf in the presence of triethylamine.

Scheme 3.20 Photo Fries Rearrangement of Two Isomers Reported by Seto

Scheme 3.21 Unsuccessful Intramolecular Photo [2+2] Reaction and Possible Reason
According to the literature,[12b,

12c]

only the endo enol ether (a series compounds) are

reactive in the [2+2] cycloaddition (Scheme 3.20). Additionally, the two regioisomers
interconvert with each other under photo conditions, presumably through a Photo-Fries
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Rearrangement.[15] Therefore, the regioisomeric mixture will not be a problem. When either 3.98
or 3.104 is irradiated by UV light, only the desired photoadduct product will be formed.
With the photoaddition precursors 3.98 and 3.104 in hand, we focused on the key step--the enone-olefin [2+2] cycloaddition step. Unfortunately, both the ketone 3.98 and 3.104 were
completely recovered without any detectable amount of the photoadduct (Scheme 3.21). We
believe that the decreased reactivity of 3.98 and 3.104 in comparison with their five-membered
ring analogue is due to steric hindrance (Scheme 3.21). This reaction is currently under study.
3.5.2 A Potential Synthesis of the Precursor by Thermal [2+2]

Scheme 3.22 Another Potential Approach to the Tricyclic Precursor
In replacing the previous route using photo [2+2] condition with thermal [2+2] via ketene,
we realized that the tricyclic skeleton could also be built by another potential route. As outlined
in Scheme 3.22, treatment of acid chloride 3.106 with amine bases results in the formation of
ketene 3.107 in situ, which will undergo an intramolecular [2+2] cycloaddition to furnish the
tricyclic 3.108. Finally, under basic conditions, the acetate 3.108 will be hydrolyzed followed by
a retro-aldol to afford the intermediate 3.109. After proton transfer process, an aldol reaction will
take place, leading to the tricyclic 3.110, which is a potential precursor of vinigrol skeleton.
Similar to the previous synthesis, diketone 3.112 was readily prepared from 1morpholinocyclohexene and mono acid chloride 3.111 (Scheme 3.23), which was obtained
according to the literature.[16] Hydrolysis of 3.112 gave the carboxylic acid 3.113 (Scheme 3.23).
Unfortunately, it turns out that the enol ether 3.116 is difficult to prepare. When the carboxylic
acid 3.113 was treated with excess amount of TBSOTf in the presence of 2,6-lutidine under
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standard conditions, only the amine salt 3.114 was detected. We tried to circumvent the problem
by forming the TBS enol ether first. Although we did get the TBS enol ether 3.115 in high yield,
3.115 was readily hydrolyzed under basic conditions to give 3.113 instead of 3.116. This
problem may be due to the incompatibility of the two functional groups: carboxylic acid and enol
ether. Currently, in order to avoid the problem, we are trying to prepare the ketene 3.107 by
some other method, like Wolff Rearrangement.[17]

Scheme 3.23 Synthetic Effort to Prepare the Thermal[2+2] Precursor
3.6 Efforts toward the Skeleton of Vinigrol Based on Thermal [2+2] Reactions
3.6.1 Initial Attempt for the Cycloaddition Reaction
As shown in Scheme 3.24, TMS enol ether 3.117 was readily formed once ketone 3.94
was treated with TMSCl in the presence of LDA at 0oC. With the enol ether 3.117 in hand, we
initiated studies on the [2+2] ring expansion to test the applicability of this strategy.
Unfortunately, our preliminary attempts at the [2+2] cycloaddition with dichloroketene did not
afford the desired tetracyclic 3.118, even though a number of different reaction conditions had
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been explored (see Table 3.2). Our attempt involved utilizing the improved procedure reported
by Hassner: preparation of dichloroketene in the presence of the enol ether and adding the
trichloroacetyl chloride to the reaction mixture very slowly in order to avoid the polymerization
of ketene itself.[18] We also tried to do the reaction under ultrasound condition, which has been
known to promote the cycloaddition of ketenes with olefins.[19]

Scheme 3.24 Efforts to Prepare the Tricyclic Core of Vinigrol by Ketene Addition
Table 3.2 Attempted [2+2] Cycloaddition Conditions toward the Tetracyclic 3.118
Entry

Reaction Conditions

Additive

Products

1

Cl3CCOCl, Zn-Cu, Et2O, r.t.

None

3.94

2

Cl3CCOCl, Zn-Cu, Et2O, reflux

None

3.94

3

Cl3CCOCl, Zn-Cu, Et2O, reflux

POCl3

3.94

4

Cl3CCOCl, Zn, Et2O, sonication at r.t.

None

3.94

5

Cl2CHCOCl, Et3N, Et2O, r.t.

None

No reaction

However, the TMS enol ether 3.117 did not react with dichloroketene, which was
prepared in situ from trichloroacetyl chloride and zinc powder[18] (Table 3.2, entries 1-4) or from
dichloroacetyl chloride and triethyl amine[20] (Table 3.2, entry 5). Instead of the tetracyclic 3.118
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we want, formation of ketone 3.94 was observed (entries 1-4), presumably due to the formation
of zinc chloride. It has been reported that phosphorus oxychloride could complex with the zinc
chloride, resulting in the removal of the zinc chloride out of the reaction system.[21] However,
this did not avoid hydrolyzing the enol ether in the reaction (entry 3). This failed result may be
due to the severe 1,3-diaxial repulsion between the chlorine and the cyclohexane ring (Scheme
3.24).

Scheme 3.25 Studies toward the [2+2] Cycloaddition with the Bicyclic Enol Ether
Bearing in mind the severe 1,3-diaxial repulsion in the cycloaddition reaction, we decided
to tackle this hurdle early rather than at a late stage of the synthesis. With the unreactive iodide
3.91b in hand, the enol ether 3.119 was readily obtained by mixing 3.91b with TMSCl in the
presence of Et3N in DMF at 90oC, and the iodine was replaced by chlorine in the same step
(Scheme 3.25). Next, the cycloaddition was carefully studied. To our surprise, although the
bicyclic chloride 3.119 is much less hindered than the tricyclic analogue 3.117, either hydroxy
ketone 3.120 or the siloxy ether ketone 3.121 was formed as the major product under standard
ketene formation conditions. These results indicate that these types of enol ethers tend to be
hydrolyzed and are unreactive toward ketene cycloaddition.
3.6.2 Revised Cycloaddition Reaction with Neutral Olefins
Although enol ethers are much more reactive toward ketene addition than neutral olefins
based upon electronic effects, enol ethers are more hindered than neutral olefins. Therefore, we
turned our attention to olefin analogues of the tricyclic precursors. As outlined in Scheme 3.26,
130

tetracyclic 3.123 will be formed from olefin 3.122 by ketene cycloaddition. Next, dechlorination
of 3.123 by zinc and acetic acid produces the ketone 3.124,[22] whose cyclobutanone ring will be
cleaved by TMSI in the presence of zinc iodide followed by elimination with DBU to furnish the
enone 3.125, the tricyclic core of vinigrol.[23]

Scheme 3.26 Synthetic Plan to Prepare the Core of Vinigrol

Scheme 3.27 Studies toward the [2+2] Cycloaddition with the Bicyclic Olefin
To this end, the iodide 3.91b was converted to the alcohol 3.126 stereoselectively by LAH
reduction of both the ketone and the iodide in one step (Scheme 3.27). Next, alcohol 3.126 was
mesylated by MsCl in the presence of Et3N in DCM at 0oC to give a mesylate, which was
eliminated in situ to afford the olefin 3.127. With the olefin 3.127 in place, we studied the
cycloaddition reaction carefully. Unfortunately, our preliminary attempts did not show any
fruitful result, although a number of different reaction conditions were explored (Table 3.3). The
first attempt we utilized was the improved procedure reported by Brady: using a high dilution
technique in order to avoid the self dimerization of ketene (Table 3.3, entry 1)[24]. We also tried
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to avoid the deprotection of the TBS ether by adding POCl3 or DME (entry 2 and 3), which are
known to be capable of complexing with the zinc salts formed in the reaction.[21] However, as
can be seen in Table 3.3, either the deprotected olefin 3.129 (entries 1-3) was formed, or
recovery of the starting material 3.127 (entries 4-5) was detected. The reason for these
unsuccessful cycloadditions may be due to the steric hindrance of the six-membered ring in the
context of the molecule, though simple six-membered ring is known to be reactive to
dichloroketene.
Table 3.3 Attempted [2+2] Cycloaddition Conditions toward the Tetracyclic 3.128
Substrate
Entry

Reaction Conditions

Additive

Products
Concentration

1

Cl3CCOCl, Zn-Cu, Et2O, reflux

None

0.05 M

3.129

2

Cl3CCOCl, Zn-Cu, Et2O, reflux

DME

0.1 M

3.129

3

Cl3CCOCl, Zn-Cu, Et2O, reflux

POCl3

0.05 M

3.129

4

Cl3CCOCl, Zn-Cu, Et2O, r.t.

None

0.05 M

No reaction

5

Cl3CCOCl, Zn, Et2O, sonication at r.t.

None

0.1 M

No reaction

3.7 Efforts toward the Skeleton of Vinigrol Based on Electrocyclic Reactions
With the failure in making the skeleton of vinigrol via thermal [2+2] reaction, we turned
our attention to the alternative route----prepare the target by an electrocyclic ring closure reaction
(see Scheme 3.10). As revealed in Scheme 3.28, the conjugated diene 3.72 can be generated via
the classic Wittig or Peterson olefination reaction from the tricyclic enone 3.130, which in turn
would arise from either bicyclic enone 3.131 or tricyclic ketone 3.94 by two possible routes.
In path A, α-elimination of the ketone 3.132 followed by an intramolecular alkylation
would furnish the tricyclic enone 3.130. In path B, by reversing the order of path A, the tricyclic
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enone 3.130 would arise from the same substrate 3.132 by an intramolecular alkylation followed
by the α-elimination of the ketone 3.94, which has been obtained from our previous synthesis. In
comparing the two pathways, while we have obtained the tricyclic ketone 3.94 in the previous
synthesis, we had a regioselective issue that needs to be solved in the alkylation step. In path A,
this alkylation problem will be circumvented by utilizing the bicyclic enone 3.131 under kinetic
conditions (only one possible enolate could be formed in this case). Therefore, we decided to
explore path A first.

Scheme 3.28 Retrosynthetic Analysis of the Conjugated Diene
3.7.1 Efforts to Prepare the Bicyclic Enone

Scheme 3.29 Studies toward the Bicyclic Enone by Direct Elimination
With the ketone 3.133 or enol ether 3.135 readily prepared from the substrate 3.85 (see
Scheme 3.14), we tried to do the direct dehydrogenation first. However, both of the two standard
procedures were unsuccessful (Scheme 3.29). When ketone 3.133 was treated with IBX in hot
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DMSO[25], complex mixtures were detected. Whereas when the enol ether 3.135 was treated with
palladium(II) acetate,[26] no reaction occurred resulting in the complete recovery of the starting
material.

Scheme 3.30 Initial Attempt to Prepare the Bicyclic Enone
Then, we focused on an aldol or aldol-like reaction aimed at introducing an extra carbon
with a good leaving group to the β-keto ester 3.75. Initially, no reaction was detected when 3.75
was treated with formaldehyde under various conditions (Scheme 3.30), but then, iodide 3.138
was formed in 60% yield when 3.75 was treated with diiodomethane in the presence of sodium
hydride in hot DMSO. Next, we planned to do the decarboxylation and elimination reactions in a
single operation by treating iodide 3.138 under base catalyzed hydrolysis conditions. However,
instead of the desired enone 3.137, a good amount of the carboxylic acid 3.139 was identified.
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The reaction likely proceeded by a retro Dieckmann condensation followed by an elimination of
the iodide.
Considering the tendency of elimination of iodides, we synthesized MOM ether 3.140
with MOM groups introduced to both the β-keto ester group and the tertiary hydroxyl group
(Scheme 3.30). However, we were surprised to find that the elimination of the MOM group was
observed to give the carboxylic acid 3.141. The strain release of the bicyclic precursor, which
has the 1,3-diaxial repulsion within the system, may be the driving force for the tendency of the
elimination to form the ring opened compounds.
In order to avoid this elimination, we tried to remove the ester group under neutral
conditions by Krapcho dealkoxycarbonylation.[27] However, only decomposition products were
detected after heating either 3.138 or 3.140 with the inorganic salts and the organic solvent
(Scheme 3.31).

Scheme 3.31 Attempted Krapcho Dealkoxycarbonylation

Scheme 3.32 Attempted Selective Reduction of the Ester Group
Next, we turned our attention to the selective reduction of the ester group of the β-keto
ester of 3.75. It has been reported that aluminum hydride can selectively reduce the ester group
in enolate salts of highly enolizable β-keto esters without attacking the enolate anion.[28] In this
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case, when 3.75 was treated by different bases followed by the reducing reagents, no reaction
could be detected (Scheme 3.32).
Table 3.4 Regioisomer Distribution in Forming the Enol Ether

Entry

Reaction Condition

Percent of 3.144

Total yield

1

2,6-Lutidine, 0oC, 2 hs

50%

90%

2

2,6-Lutidine, r.t., 3 hs

83%

100%

3

Et3N, r.t., 10 hs

100%

98%

Scheme 3.33 Successful Synthesis of the Bicyclic Enone
Then we considered the possibility of locking the enol form of 3.75 by mixing it with
silicon reagents. Since we also need to protect the hydroxyl group of 3.75, we chose to use
TBSOTf. When 3.75 was mixed with TBSOTf in the presence of triethyl amine, the silyl enol
ether with the protected hydroxyl product 3.144 was formed in 98% yield (Table 3.4, entry 3).
We found that both the base and the temperature are crucial for the regioselectivity (Table 3.4). It
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seems that triethylamine promotes the formation of the desired isomer 3.144. Also, the higher the
temperature is, the more distribution of 3.144 there will be.
Next, reduction of both the enol ether and the ester was accomplished in one step by
treating 3.144 with LAH at 0oC to afford the desired α-hydroxyl ketone 3.146, which was
converted to the bicyclic enone 3.148 by mesylation and elimination (Scheme 3.33).

Scheme 3.34 Attempt Functionalization of the Allylic Double Bond
With the enone 3.148 in hand, we were focused on the functionalization of the terminal
double bond. However, this enone turned out to be a tough compound to handle. In this scenario,
the enone competes with the allyl double bond. Hydroboration of the enone 3.148 with 9-BBN
followed by oxidation afforded a complex mixture, whose major component was identified to be
the carbonyl reduced product (Scheme 3.34). Hydroboration of 3.148 with dicyclohexylborane
followed by oxidation gave a mixture of alcohols including 3.146, which was produced from the
hydroboration of the enone carbon-carbon double bond. When 3.148 was treated with m-CPBA
under standard conditions, instead of the epoxide we want, the lactone 3.150 was formed,
presumably from a Baeyer-Villiger reaction. We tried to avoid this reaction by adding sodium
bicarbonate into the reaction mixture, but the same lactone 3.150 was obtained (Scheme 3.34).
Bearing in mind the high reactivity of the enone, we realized that we needed to
functionalize the terminal olefin before the enone was generated. Thus, the β-hydroxy ketone
3.146, the precursor for the enone, was selected. It seems that the sequence of the transformation
is critical. In the event, when 3.146 was treated with dicyclohexyl borane followed by sodium
perborate afforded the diol 3.151, which was transformed to the diiodide 3.152 under standard
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conditions (Scheme 3.35). However, decomposed products were identified after mixing the
diiodide 3.152 with DBU. To this end, the diol was converted to a dimesylate and
chemoselectively eliminated the mesylate next to the carbonyl group by DBU, forming the
bicyclic enone 3.154 in 89% yield. Mesylate 3.154 was further substituted by iodide to afford the
desired iodide 3.153, the precursor for cyclization (Scheme 3.35).
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Scheme 3.35 Synthetic Effort to Prepare the Enone Iodide

Scheme 3.36 Self Dimerization of the Bicyclic Enone
It is worth noting that the bicyclic enones (3.148, 3.153 and 3.154) are unstable. Without
the presence of any solvent, they will self dimerize at room temperature presumably through a
hetero Diels-Alder reaction in a regio- and stereoselective manner (Scheme 3.36). Indeed, this
self dimerization of methylene ketone has been reported in the literature.[29] Besides, this self
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dimerization of the bicyclic enone can be prevented by storing the pure compound in a solution
rather than neat.

Scheme 3.37 First Generation Synthesis of the Bicyclic Enone Iodide
In summary, we have developed a concise route to the bicyclic enone 3.153, which is a
potential precursor of vinigrol (summarized in Scheme 3.37). Key elements of the sequence
involve selective reduction of the ester group of β-keto ester by masking the ketone with TBS
silyl ether and the sequence of functionalizing the terminal olefin.
3.7.2 An Alternative Route to Prepare the Bicyclic Enone
Although the above route to prepare the bicyclic enone 3.153 is efficient and high yielding,
the obtained enone 3.153 is a diastereomeric mixture with the desired isomer as the minor
component (ratio = 1:4.3) because we started the synthesis from bicyclo[3.3.1] nonane 3.75. No
epimerization occurred thereafter. Therefore, we developed a second route to access the enone,
aiming to obtain the desired diastereomer as the major component. As outlined below (Scheme
3.38), the synthesis was commenced with the previously obtained TBS enol ether 3.86, which
was a 1:1 mixture of the two diastereomers at the bridgehead of bicyclo[3.3.1]nonane system.
This second generation route proved to be fruitful. The enone 3.149 was prepared with a
44% yield by exposure of the silyl enol ether 3.86 to NBS in THF at -78oC, followed by
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elimination with DBU. Then, the enone 3.149 was converted to the iodide 3.153 by standard
procedure.

Scheme 3.38 Second Generation Synthesis of the Bicyclic Enone Iodide
Having the iodide 3.153 in hand, our next challenge was to close the third ring.
Unfortunately, our preliminary attempts at the cyclization did not afford the desired tricyclic
enone product 3.159. At lower temperature, the starting material 3.153 was recovered, whereas
elimination products were identified at higher temperature (Table 3.5). Although 3.153 is a
mixture of the diastereomers (1:1 ratio), it is sufficient for us to test the applicability of the
reaction. The reluctance of the bicyclic enone to cyclize may be caused by the reduced
accessibility or reactivity of the cross-conjugated enolate.
Table 3.5 Attempted Enone Cyclization Reaction Conditions
Entry

Reaction Condition

Result

1

KOtBu, THF, 12 hs at 0oC

No reaction

2

LDA, HMPA, THF, 24 hs at 0oC

No reaction

3

LDA, HMPA, THF, 3 hs at r.t.

E2 elimination product formed
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3.7.3 Efforts to Prepare the Tricyclic Enone

Scheme 3.39 Attempted Direct Dehydrogenation of the Tricyclic
We, therefore, decided to explore path B, cyclization first followed by elimination to
access the tricyclic enone. Initial attempts to effect the direct unsaturation of the ketone 3.94 with
IBX in hot DMSO[25] resulted in multiple spots on TLC, without producing any major products
(Scheme 3.39). The alternative route to access the enone by exposure of the corresponding TMS
enol ether 3.117 to palladium acetate in acetonitrile[26] proved unfruitful as well.

Scheme 3.40 Preparation of the Tricyclic Enone
In an effort to find a viable route to the tricyclic enone, a selenation of the ketone 3.94
followed by an oxidative elimination to introduce the resident olefin was suggested. Thus, the
ketone 3.94 was selenated with LDA and PhSeI, which was generated in situ by treating
diphenyl diselenide with iodine, to afford the selenide 3.160 with approximately 30% conversion
(Scheme 3.40). And this was the optimized condition we found (only 20% conversion was
observed if PhSeBr was used as the selenating reagent). Due to the low conversion of this step,
we recycled the crude product with LDA and PhSeI one more time. The reluctance of 3.94 to
undergo selenation may be due to the associated 1,3-diaxial repulsion.
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Subsequent oxidation of the selenide 3.160 with m-CPBA followed by diisopropyl amine
furnished the desired tricyclic enone 3.159 in 58% yield after two cycles of the first step
(Scheme 3.40).
It is worth mentioning that 3.160 was found to eliminate to 3.159 at r.t. without any
chemical treatment. The release of the steric strain may be the driving force for this elimination.
Two possible mechanisms were suggested: either oxidation of 3.160 by air or homocleavage of
the carbon-selenium bond via a radical pathway.

Scheme 3.41 An Alternative Route to Prepare the Tricyclic Enone
Although 3.159 has been successfully prepared, the above route requires the use of a large
excess of very toxic selenium reagent, and the synthesis appears to be tedious (the first step
needs to be recycled twice) and low yielding. An alternative route utilizing the previously
obtained TMS enol ether 3.117 was explored. The enol ether 3.117 was smoothly converted to
the bromide 3.161 by mixing with NBS in THF at -78oC for one hour (Scheme 3.41). The
elimination step appears slower than the selenide route. A large excess base DBU (5.0 eq.) was
needed, and the temperature was increased to reflux (no reaction was detected at r.t.) for 18
hours. This route to access the enone 3.159 was high yielding and convenient, though it required
an additional step to prepare 3.117 from 3.94.
3.7.4 Efforts to Prepare the Conjugated Diene
With the tricyclic enone 3.159 in hand, efforts were focused on the olefination of 3.159 to
provide the conjugated diene 3.162, the precursor for the electrocyclic ring closure reaction.
However, it turns out that the carbonyl group of the enone 3.159 is unreactive. No reaction was
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observed under either standard or modified Wittig reaction conditions (Table 3.6, entries 1-2).
Decomposed products were detected when 3.159 was treated with deprotonated ylide (entry 3) or
Petasis reagent (entry 4). Under Peterson olefination condition, multiple products without
olefinic hydrogen (proved by 1H NMR) were detected, indicating the formation of conjugate
addition products (entry 5). This tendency for conjugate addition may be due to the high steric
congestion of the enone carbonyl group. In order to minimize this steric issue, we added
methyllithium, which is a very small nucleophile, to the reaction. Surprisingly, similar results
were observed after 3.159 reacted with methyllithium (entry 6).
Table 3.6 Attempted Enone Olefination Conditions

Entry

Reaction Conditions

Results

1

Ph3P=CH2, THF, 0oC

No reaction

2

Ph3P=CH2, DMSO, 80oC

No reaction

3

Ph3P=CHLi, THF, 0oC

Decomposed

4

Cp2TiMe2, toluene, 65oC

Decomposed

5

TMSCH2Li, CeCl3, THF, 0oC

Multiple products without the desired product

6

MeLi, Et2O, -78 oC

Multiple products including the conjugate addition
product but no signs of the desired product

Considering the unreactive nature of the carbonyl group in the tricyclic enone system, we
decided to convert this carbonyl group to an alkene earlier in the synthesis. In the event, the
ketone 3.94 was smoothly converted to the alcohol 3.163 stereoselectively by mixing 3.94 with
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methyllithium in the presence of cerium (III) chloride in THF (Scheme 3.42). Then the alcohol
3.163 underwent a regioselective dehydration reaction to afford the alkene 3.164 by treating
3.163 with Burgess reagent. Next, allylic bromination of 3.164 with NBS will lead to the allylic
bromides 3.165 and 3.166. Subsequent elimination of the allylic bromides mixture will deliver
the conjugated diene 3.162. The last two steps are currently under study in our lab.

Scheme 3.42 Another Potential Route to the Conjugated Diene
3.8 Future Plan
In order to solve the syn relationship between the methyl and hydroxyl group in vinigrol,
we come up with a model study as depicted in Scheme 3.43. The commercially available (S)carvone is methylated to give 3.167, which is subjected to base catalyzed Robinson annulation to
afford 3.168. Based on our previous experimental studies, 3.168 will be a mixture of
diastereomers with the anti product as the major component. Treatment of 3.168 with HBr will
afford, after decarboxylation, base catalyzed epimerization and elimination of the bromide in one
step, the desired compound 3.170. The syn relationship between the methyl and hydroxyl group
is anticipated because of the unfavored A1,3 strain associated with the anti isomer. And the
bridgehead methyl group of the [3.3.1] system has to be syn to the carbonyl in order to avoid the
1,3-diaxial repulsion with the other methyl group.
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Scheme 3.43 A Model Study on the Stereocenters Formed in [3.3.1] System
If the model study is successful, we can elaborate it to the synthesis of vinigrol. As shown
in Scheme 3.44, a Robinson annulation between 3.171 and acetoacetate will give 3.172 as a
mixture in favor of the anti isomer. Methylation of 3.172 followed by chemoselective
hydrobromination will afford, after decarboxylation, elimination and epimerization in one step,
the desired compound 3.174. Removal of the isopropylidene group will be the next target.
Several steps of transformations, including protection of the carbonyl group to a cyclic acetal,
chemoselective hydroboration-oxidation of the allyl double bond, protection of the resulting
alcohol, ozonolysis of the isopropylidene group, protection of the resulting carbonyl group with
thiols, hydrogenolysis of the resulting dithio acetal and deprotection of the cyclic acetal, will
furnish 3.175.
Next, similar transformations as our previous synthesis, containing deprotection of the
hydroxyl group, conversion of the alcohol to iodide and alkylation, will secure the tricyclic 3.176,
which could be converted to the conjugated diene 3.177 according to our previous experimental
studies. Enone 3.178 can be obtained by deprotection of the hydroxyl group of 3.177, oxidation,
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elimination with IBX and Baylis-Hillman reaction with formaldehyde. Next, an electrocyclic
reaction followed by ozonolysis will furnish the diketone 3.180, which can be transformed to
3.181 through chemoselective Wittig reaction and stereoselective hydrogenation of the resulting
double bonds. Finally, deprotection of the hydroxyl group of 3.181 followed by a stereoselective
reduction will afford vinigrol.

Scheme 3.44 Potential Synthesis of Vinigrol
3.9 Conclusion
Efforts toward the total synthesis of vinigrol (3.01) have been described. It has been
realized that vinigrol can be built by two potential pathways starting from the same tricyclic
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precursor based on a two-carbon ring expansion strategy. The tricyclic precursor has been
efficiently prepared in gram scale utilizing the Robinson annulation, base catalyzed
epimerization and intramolecular alkylation as the pivotal steps.
It was hoped that the thermal [2+2] reaction with dichloroketene would generate the
bridging eight-membered ring. Unfortunately, this step remains in vain presumably due to steric
congestion. We are exploring an alternative route using the tricyclic enone as the electrocyclic
reaction precursor. Although the bicyclic enone has been synthesized in high yield via either
indirect or direct pathways, the intramolecular cyclization remains elusive.
Finally, the tricyclic enone can be obtained from the tricyclic precursor via either a
selenation- or a bromination-elimination sequence. Further transformation involving olefination,
electrocyclic reaction and oxidative cleavage to generate the bridging eight-membered ring
would complete the synthesis of the vinigrol core.
3.10

Experimental Section

3.10.1 General Considerations
Reactions were carried out in oven or flame-dried glassware under a nitrogen atmosphere,
unless otherwise noted. All solvents were freshly distilled and dried by standard techniques just
before use. Diethyl ether and THF were distilled from sodium/benzophenone. Methylene
chloride (CH2Cl2), benzene (PhH), and diisopropylamine were distilled from calcium hydride.
Anhydrous pyridine (Py), triethylamine, N,N-dimethylformamide (DMF), acetonitrile (MeCN),
and dimethyl sulfoxide (DMSO) were purchased from Aldrich and used without purification.
n

butyllithium (nBuLi) was purchased from Aldrich and titrated against 1,3-diphenyl-2-propanone

p-toluenesulphonylhydrazone prior to use. Trimethylsilyl trifluoromethanesulfonate (TMSOTf)
and trimethylsilyl chloride were distilled from calcium hydride. Except as indicated otherwise,
all other reagents were purchased from Sigma-Aldrich, Acros, or Cambridge Isotope
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Laboratories, Inc. and used as received. Reactions were monitored by thin layer chromatography
(TLC) with 0.20-mm pre-coated silica gel plates (aluminum backing, Sorbent Technologies).
Spots were detected by viewing under a UV light, putting into an iodine chamber, or colorizing
with charring after dipping in an anisaldehyde solution composed of acetic acid, sulfuric acid,
and methanol. Silica gel for flash chromatography (particle size 0.032-0.063 mm) was supplied
by Sorbent Technologies. Yields refer to chromatographically and spectroscopically pure
compounds, unless otherwise stated.
1

H NMR spectra was recorded on a Bruker AV-400 (400 MHz 1H) spectrometer in

deuterated solvents using the solvent residual protons as an internal reference (CDCl3: 7.26 ppm
1

H) for 1H NMR or using solvent carbons as an internal reference for 13C NMR (CDCl3: 77.00

ppm, t for

13

C NMR). Chemical shifts (δ) are given in parts per million down from

tetramethylsilane (TMS). Data for 1H NMR spectra are reported as follows: chemical shift (δ
ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quin =quintet, dd = doublet of
doublets, m = multiplet, br = broad), coupling constant (Hz), and integration. High-resolution
mass spectra (HRMS) were recorded on Agilent LC/MS 6210-TOF (Time-Of-Flight) mass
spectrometer by electrospray ionization time of flight reflectron experiments.
3.10.2 Preparative Procedures

To 440 mL of a freshly prepared sodium methoxide in methanol solution (1.5 M, 0.66
mol) was added 54.9 ml of methyl thioglycolate (0.60 mol) dropwise at 0oC. To the resulting
solution was then added a solution of 2-cyclohexen-1-one (58.0 g, 0.60 mol) in 130 ml of
methanol. The solution was refluxed overnight. After removal of the solvent, the brown residue
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was acidified by 3N HCl and extracted with DCM. The combined organic layers were dried and
concentrated to give a reddish oil, which was taken on to the next step without further
purification.
To a mechanically stirred solution of the above product in 550 ml of acetone was added
potassium carbonate (125.4 g, 0.9 mol) and allyl bromide (78.5 ml, 0.9 mol). The resulting
solution was refluxed overnight. The inorganic salts were separated by filtration through sintered
glass funnel. The filtrate was concentrated and taken on to the next step without further
purification.
To the above concentrated product was added 608 ml of ether and then 243 ml of a 5.0 M
aqueous sodium hydroxide solution at room temperature. After stirring for five hours, the
solution was separated. The aqueous layer was extracted with ether (3×200 ml). The combined
organic layers were dried (MgSO4), filtered and concentrated. The crude residue was purified by
flash chromatography on silica gel (Hex/EA = 7:1) yielded the titled compound (31.2 g, three
steps yield: 38%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3): δ 6.72-6.74 (t, J= 4 Hz, 1H),
5.76-5.86 (m, 1H), 5.02-5.06 (m, 2H), 2.94-2.96 (m, 2H), 2.42-2.45 (m, 2H), 2.35-2.37 (m, 2H),
1.96-2.00 (m, 2H).
See Chapter 2 for the preparation of 3.75 and 3.76.

To an ice-cold solution of the ketone 3.76 (1.1 g, 4.13 mmol) in 20 ml of dry CH2Cl2 was
added 2,6-lutidine (1.77 g, 16.5 mmol) and TBSOTf (2.40 g, 9.09 mmol) sequentially, dropwise
and the resulting reaction mixture was stirred at r.t. for 3 hours. Then the mixture was poured
into 30 ml of saturated NaHCO3 at 0oC. The solution was extracted thoroughly with CH2Cl2, and
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the organic extracts were dried over Na2SO4 and filtered. Removal of the solvent under reduced
pressure followed by column with hexane as the eluent to give the product 3.77 (1.82 g, 89%) as
colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.64-5.74 (m, 1H), 4.94-5.03 (m, 2H), 4.72 (s, 1H),
3.63 (s, 3H), 2.54-2.58 (m, 1H), 2.00-2.05 (m, 1H), 1.84-1.89 (m, 3H), 1.30-1.70 (m, 8H), 0.88
(s, 9H), 0.87 (s, 9H), 0.19 (d, J = 4 Hz, 6H), 0.09 (d, J = 4 Hz, 6H).

A solution of the substrate 3.77 (0.87 g, 1.76 mmol) in 8.8 ml of THF was cooled to 0 oC,
and a solution of 9-BBN in THF (0.5 M, 3.5 ml, 1.76 mmol) was added dropwise under nitrogen.
The solution was slowly (about 2 hours) warmed to r.t. and stirred for 3 hours at r.t. (the reaction
was judged complete by TLC). The reaction mixture was opened to air and NaOH solution (3 M,
3.5 ml, 10.6 mmol) was added. The mixture was cooled to 0 oC and H2O2 (1.5 ml, 30% max., 14
mmol) was added dropwise followed by MeOH (1 ml). The resulting mixture was warmed to r.t.
and stirred for an additional 3 hours. Then the organic solvent was moved in vacuo, and the
residue was diluted with ethyl acetate and washed with saturated NaHCO3 and brine. The
organic layer was dried over MgSO4, filtered, concentrated and purified by silica gel
chromatography (Hex/EA = 5:1) to give the product (0.77 g, 85%) as colorless oil. 1H NMR (250
MHz, CDCl3): δ 4.70 (s, 1H), 3.63 ( br s, 5H), 1.60-1.80 (m, 8H), 1.35-1.44 (m, 7H), 0.87 (s,
9H), 0.85 (s, 9H), 0.18 (s, 6H), 0.07 (s, 6H).

13

C NMR (62.5 MHz, CDCl3): δ 175.27, 151.89,

111.80, 75.33, 63.04, 53.34, 51.06, 43.64, 42.26, 32.43, 30.88, 25.72, 25.47, 22.95, 22.50, 20.76,
19.85, 18.07, 17.83, -1.99, -2.34, -4.31, -5.40.
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To a stirred solution of the alcohol 3.81 (0.66 g, 1.29 mmol) and Et3N (0.41 ml, 2.96
mmol) in 5.5 ml of CH2Cl2 in an ice bath under nitrogen, was added dropwise MsCl (0.12 ml,
1.54 mmol). The resulting solution was stirred for 1 hour at 0oC, sat. aqueous NH4Cl (3 ml) was
then added and the mixture was extracted with CH2Cl2 (3  6 ml). The combined organic phases
were washed with brine, dried (MgSO4) and concentrated to give the crude product, which was
purified by flash chromatography (Hex/EA = 5:1) to yield the mesylate (0.672 g, 88%) as
colorless oil. 1H NMR (250 MHz, CDCl3): δ 4.73 (s, 1H), 4.24 (t, J = 5 Hz, 2H), 3.66 (s, 3H),
3.00 (s, 3H), 1.70-1.84 (m, 5H), 1.50-1.60 (m, 3H), 1.39-1.46 (m, 7H), 0.89 (s, 9H), 0.87 (s, 9H),
0.20 (s, 6H), 0.09 (s, 6H).

To a solution of the mesylate 3.82 (0.205 g, 0.35 mmol) in 2.3 ml of THF at -78oC was
added a solution of TBAF (1.0 M, 0.36 ml, 0.36 mmol) in THF. Then the reaction mixture was
increased to 0oC and stirred for 1.5 hours, and then quenched with water. The mixture was then
extracted with ethyl acetate and the combined organic phases were washed with brine, dried
(MgSO4), filtered and concentrated. Column chromatography (Hex/EA = 3:1) afforded the
product (0.13 g, 80%) as colorless oil. 1H NMR (250 MHz, CDCl3): δ 4.23 (t, J = 5 Hz, 2H),
3.69 (s, 3H), 2.98 (s, 3H), 2.58-2.64 (m, 2H), 1.60-1.80 (m, 4H), 1.22-1.60 (m, 11H), 0.83 (s,
9H), 0.06 (s, 6H).
See Chapter 2 for the preparation of 3.85.
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A procedure analogous to that used for 3.77 afforded the product (5.6 g, 89% as using 3.0
g of the SM) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.72-5.82 (m, 1H), 4.97-5.06 (m,
2H), 2.54-2.57 (m, 1H), 2.23-2.27 (m, 1H), 2.02-2.14 (m, 1H), 1.60-1.70 (m, 2H), 1.50-1.55 (m,
8H), 1.27 (br s, 3H), 0.96 (s, 9H), 0.87 (s, 9H), 0.15 (d, J = 6 Hz, 6H), 0.08 (d, J = 7 Hz, 6H). 13C
NMR (100 MHz, CDCl3): δ 142.19, 138.78, 115.14, 114.20, 74.31, 48.50, 46.30, 38.49, 36.18,
30.10, 25.86, 19.98, 19.36, 18.24, 18.15, 14.83, -1.80, -1.91, -3.59, -3.85. HRMS (ESI): m/z
calcd. for (C25H48O2Si2+H+): 437.3266; found: 437.3260.

A procedure analogous to that used for 3.81 afforded the alcohol (4.47 g, 99% as using
4.34 g of the SM) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 3.60-3.69 (m, 2H), 2.40-2.41
(m, 1H), 2.33-2.37 (m, 2H), 1.40-1.80 (m, 11H), 1.35 (br s, 3H), 0.96 (s, 9H), 0.86 (s, 9H), 0.14
(d, J = 6 Hz, 6H), 0.07 (d, J = 6 Hz, 6H).

13

C NMR (100 MHz, CDCl3): δ 142.41, 142.26,

114.04, 109.80, 75.17, 74.64, 63.54, 63.49, 49.07, 48.46, 46.53, 43.51, 43.18, 40.99, 39.28,
36.22, 31.54, 31.45, 28.38, 25.90, 25.66, 22.76, 21.21, 20.31, 20.26, 19.33, 18.23, 18.16, 15.25,
14.91, -1.79, -1.83, -3.56, -3.67, -3.85. HRMS (ESI): m/z calcd. for (C25H50O3Si2+H+): 455.3371;
found: 455.3360.
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A procedure analogous to that used for 3.83 afforded the 3.87 (2.8 g, 84% as using 4.47 g
of the SM) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 3.70 (t, J = 5 Hz, 2H), 2.64-2.68 (m,
1H), 2.40-2.58 (m, 2H), 2.37-2.38 (m, 1H), 1.85-1.87 (m, 2H), 1.73-1.76 (m, 2H), 1.45-1.56 (m,
6H), 1.10-1.30 (m, 1H), 1.08 (d, J = 7 Hz, 3H), 0.86 (s, 9H), 0.08 (s, 6H). 13C NMR (100 MHz,
CDCl3): δ 212.45, 75.96, 62.96, 57.01, 49.98, 48.92, 40.98, 38.76, 34.85, 31.34, 27.26, 25.72,
21.89, 19.35, 18.84, 18.02, 11.85, -1.91. HRMS (ESI): m/z calcd. for (C19H36O3Si+Na+):
363.2326; found: 363.2332.

A procedure analogous to that used for 3.82 afforded mesylate 3.90 (1.48 g, 93% as using
1.3 g of the SM) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.28 (br s, 2H), 3.02 (s, 3H),
2.50-2.69 (m, 2H), 1.70-2.10 (m, 7H), 1.24-1.58 (m, 6H), 1.08 (t, J = 7 Hz, 3H), 0.87 (s, 9H),
0.09 (s, 6H).

To dry DCM (28 ml) was added in this order: triphenylphosphine (2.18 g, 8 mmol),
imidazole (0.56 g, 8 mmol) and iodine (2.11 g, 8 mmol). A solution of the alcohol 3.87 (2.35 g, 7
mmol) in 7 ml of dry DCM was added and the mixture was stirred at room temperature for two
hours. Then the solvent was removed in vacuo and the product was purified by passing it through
a column (Hex/EA = 20:1) to afford the product 3.91 (2.9 g, 93%) as pale yellow crystalline
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solid. 1H NMR (400 MHz, CDCl3): δ 3.20-3.26 (m, 2H), 2.65-2.68 (m, 1H), 2.34-2.49 (m, 2H),
2.11-2.15 (m, 1H), 1.96-1.98 (m, 2H), 1.73-1.85 (m, 3H), 1.46-1.56 (m, 4H), 1.22-1.24 (m, 1H),
1.05 (d, J = 7 Hz, 3H), 0.88 (s, 9H), 0.09 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 211.86, 76.48,
51.40, 49.17, 42.65, 41.12, 39.06, 32.01, 27.31, 27.26, 25.89, 20.08, 19.03, 11.94, 6.96, -1.77.
HRMS (ESI): m/z calcd. for (C19H35IO2Si+H+): 451.1524; found: 451.1499.

To a solution of dry TMP (1.14 ml, 6.56 mmol) in 7.0 ml of THF was added nbutyllithium
solution (1.6 M, 4.1 ml, 6.56 mmol) slowly at -78oC under N2 and increased the temperature to
0oC. After 15 minutes stirring at 0oC, the mixture was cooled to -78oC. A solution of the
substrate 3.91 (1.97 g, 4.37 mmol) in 27 ml of THF was added dropwise to the mixture at -78 oC,
and the resulting mixture was slowly warmed to -15 oC during the next one hour, and stirring was
continued overnight. Saturated aqueous NH4Cl (10 ml) was added and diluted with 50 ml of
ether, separated. The organic layer was washed with water (2×8 ml), brine (10 ml), dried over
MgSO4, filtered and concentrated under reduced pressure. The crude product NMR indicated that
the ratio of two isomers is around 3.8:1. The residue was purified by column (Hex:EA = 30:1) to
give the unreactive isomer 3.91b (0.80 g) and the desired tricyclic product 3.94 (0.56 g, 40%) as
white crystalline solid. 1H NMR (400 MHz, CDCl3): δ 2.64-2.70 (m, 1H), 2.40-2.47 (m, 3H),
2.19-2.39 (m, 1H), 1.78-1.83 (m, 3H), 1.58-1.76 (m, 1H), 1.52-1.56 (m, 5H), 1.38-1.42 (m, 1H),
1.23-1.30 (m, 1H), 1.07 (d, J = 7 Hz, 3H), 0.92 (s, 9H), 0.11 (d, J = 7 Hz, 6H). 13C NMR (100
MHz, CDCl3): δ 216.76, 75.09, 57.95, 45.48, 44.10, 42.31, 41.47, 28.02, 26.09, 25.64, 24.45,
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19.65, 18.65, 18.57, 12.40, -1.59, -1.77. HRMS (ESI): m/z calcd. for (C19H34O2Si+H+):
323.2401; found: 323.2396.

To a stirred solution of the ketone 3.85 (1.23 g, 5.9 mmol) in 100 ml of dichloromethane/
diisopropyl ethylamine (1:1) at 0oC was added dropwise MOMCl (4.5 ml, 59 mmol). After
stirring 24 hours at r.t., the reaction mixture was diluted with 50 ml of DCM and the organic
layer was washed with 50 ml of 3N HCl. The aqueous washes were back extracted with DCM
(3×50 ml), and the combined organic layers were washed with brine, dried (MgSO4), filtered and
concentrated. The residue was chromatographed on silica gel (Hex/EA = 10:1) yielded the titled
compound (1.08 g, 73%) as pale yellow oil. 1H NMR (400 MHz, CDCl3): δ 5.76-5.83 (m, 1H),
5.05- 5.12 (m, 2H), 4.79 (d, J = 7.0 Hz, 1H), 4.70 (d, J = 7.0 Hz, 1H), 3.37 (s, 3H), 2.71-2.79 (m,
1H), 2.60-2.68 (m, 2H), 2.36-2.39 (m, 1H), 2.09-2.22 (m, 2H), 1.48-1.75 (m, 6H), 1.20-1.33(m,
1H), 1.08 (d, J = 7.0 Hz, 3H). HRMS (ESI): m/z calcd. for (C15H24O3+Na+): 275.1618; found:
275.1630.

Borane-tetrahydrofuran (1.0 M in THF, 0.46 ml, 0.46 mmol) was placed in a dry,
nitrogen-flushed, round-bottomed flask, which was then immersed in an ice-water bath.
Cyclohexene (0.093 ml, 0.92 mmol) was added dropwise and the mixture stirred at 0oC for one
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hour. The substrate 3.88 (116 mg, 0.46 mmol) in 0.3 ml of THF was then added to the slurry of
dicyclohexylborane in THF. The cooling bath was removed and the mixture stirred for two hours
at r.t. Oxidation was achieved by adding NaBO3·4H2O (0.212 g, 1.38 mmol) and water (0.5 ml)
and stirring was continued at r.t. for two more hours. The product was extracted into ether (3×3
ml), dried (MgSO4), filtered and concentrated. The residue was chromatographed on silica gel
(Hex/EA = 1:1) yielded the title compound (120 mg, 97%) as colorless oil. 1H NMR (250 MHz,
CDCl3): δ 4.70 (d, J = 7.0 Hz, 1H), 4.64 (d, J = 7.0 Hz, 1H), 3.61 (t, J = 6.0 Hz, 2H), 3.29 (s,
3H), 2.56-2.65 (m, 3H), 2.32-2.34 (m, 1H), 2.12 (br s, 1H), 1.80-2.00 (m, 1H), 1.63-1.79 (m,
4H), 1.41-1.45 (m, 4H), 1.15-1.19 (m, 1H), 1.01 (d, J = 6.8 Hz, 3H).

13

C NMR (62.5 MHz,

CDCl3): δ 211.92, 89.94, 78.16, 62.50, 55.17, 53.35, 48.70, 46.65, 38.91, 31.35, 30.80, 21.88,
18.97, 18.65, 12.08. HRMS (ESI): m/z calcd. for (C15H26O4+Na+): 293.1723; found: 293.1730.

The alcohol 3.89 (94 mg, 0.35 mmol) was dissolved in THF (2.3 ml) and treated with
imidazole (59.2 mg, 0.87 mmol) and triphenylphosphine (109.4 mg, 0.42 mmol). The mixture
was cooled to 0 oC and iodide (106 mg, 0.42 mmol) was added in two portions (or added
portionwise over 10 minutes). The reaction mixture was stirred at 0 oC for two and half hours,
warmed to ambient temperature and stirred for an additional one hour. The reaction mixture was
quenched with saturated sodium thiosulphate (0.16 ml) and water (0.33 ml) and then stirred for
30 minutes at ambient temperature, poured into water (1.6 ml) and extracted with ethyl acetate
(2×3.2 ml). The combined organic layers were dried with MgSO4, filtered and concentrated in
vacuo. The residue was chromatographed on silica gel (Hex/EA = 5:1) yielded the titled
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compound (126 mg, 95%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.76 (d, J = 7.50 Hz,
1H), 4.70 (d, J = 7.50 Hz, 1H), 3.36 (s, 3H), 3.19-3.29 (m, 2H), 2.76 (d, J = 15.0 Hz, 1H), 2.65
(d, J = 15.0 Hz, 1H), 2.37-2.40 (m, 1H), 2.14 (br s, 1H), 1.86-2.02 (m, 4H), 1.72-1.74 (m, 2H),
1.48-1.54 (m, 4H), 1.21-1.24 (m, 1H), 1.08 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
211.57, 90.17, 78.00, 55.42, 53.56, 48.85, 46.64, 39.22, 32.33, 31.55, 27.26, 19.29, 18.79, 12.27,
7.10. HRMS (ESI): m/z calcd. for (C15H25IO3+Na+): 403.0741; found: 403.0737.

A procedure analogous to that used for 3.94 afforded the unreactive isomer 3.93b (1.9 g)
and the product (0.9 g, 27% as using 5.0 g of the SM) as colorless oil. 1H NMR (400 MHz,
CDCl3): δ 4.70 (d, J = 6.80 Hz, 1H), 4.68 (d, J = 6.80 Hz, 1H), 3.35 (s, 3H), 2.69 (t, J = 6.8 Hz,
1H), 2.60 (br s, 1H), 2.20-2.28 (m, 3H), 1.92 (br s, 1H), 1.70-1.81 (m, 3H), 1.48-1.59 (m, 5H),
1.35-1.39 (m, 1H), 1.19-1.28 (m, 1H), 1.04 (d, J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
215.82, 89.76, 76.85, 55.52, 54.88, 45.73, 42.37, 41.32, 36.64, 27.84, 25.43, 24.12, 19.13, 18.66,
12.40. HRMS (ESI): m/z calcd. for (C15H24O3+H+): 253.1798; found: 253.1789.

The enamine (1.39 ml, 8.27 mmol) was dissolved in 8.8 ml of dry chloroform and treated
with triethyl amine (1.16 ml, 8.32 mmol). To the resulting mixture kept at 40oC was slowly
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added a solution of 5-hexenoyl chloride (1.0 g, 7.54 mmol) in 6.6 ml of chloroform. After
stirring at r.t. for further 12 hours, concentrated aqueous HCl (2.2 ml) and water (1.1 ml) were
added. The resulting mixture was refluxed for five hours and the organic phase was washed with
water until neutral. The combined aqueous phases were neutralized with aqueous NaOH and reextracted with chloroform. The combined organic extracts were dried over MgSO4, filtered and
concentrated to leave a residue, which was chromatographed on silica gel (Hex/EA = 15:1)
yielded the titled compound (1.0 g, 68%) as pale yellow oil. 1H NMR (400 MHz, CDCl3): δ
5.70-5.76 (m, 1H), 4.90-4.99 (m, 2H), 2.35 (t, J = 7.5 Hz, 2H), 2.25-2.26 (m, 4H), 2.01-2.07 (m,
2H), 1.61-1.68 (m, 7H). 13C NMR (100 MHz, CDCl3): δ 201.17, 181.47, 137.98, 115.03, 106.64,
36.02, 33.18, 31.04, 23.71, 23.27, 22.81, 21.62.

To a cold (0oC) stirred solution of the substrate (138 mg, 0.71 mmol) in dry pyridine (3.4
ml) under nitrogen was added acetyl chloride (0.076 ml, 1.07 mmol), and the resulting mixture
was stirred at 0oC overnight. The mixture was poured into ice-cold aqueous HCl, and then
extracted with ether. The combined organic extracts were washed with aqueous HCl then brine,
dried (Na2SO4), filtered and evaporated. The residue was purified by column (Hex/EA = 10:1) to
afford an inseparable mixture of 3.98a and 3.98b (72 mg, 43%, ratio = 10:1 as indicated by
NMR) as colorless oil. Major component: 1H NMR (400 MHz, CDCl3): δ 5.73-5.80 (m, 1H),
4.95-5.02 (m, 2H), 2.54 (t, J= 7.4 Hz, 2H), 2.33-2.36 (m, 2H), 2.26-2.29 (m, 2H), 2.17 (s, 3H),
2.05 (q, J = 7.1 Hz, 2H), 1.64-1.72 (m, 7H). 13C NMR (100 MHz, CDCl3): δ 201.01, 168.48,
153.27, 138.20, 125.76, 115.08, 41.45, 33.18, 28.62, 25.06, 22.78, 22.15, 21.73, 21.21.
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A procedure analogous to that used for 3.77 afforded an inseparable mixture of 3.104a and
3.104b (0.23 g, 90% as using 0.16 g of the SM, ratio = 3.6 :1) as colorless oil. 1H NMR (400
MHz, CDCl3): δ 5.74-5.81 (m, 1H), 4.98 (d, J = 17 Hz, 1H), 4.92 (d, J = 9.8 Hz, 1H), 2.75 (t, J =
7.5 Hz, 2H), 2.24 (t, J = 7.0 Hz, 2H), 2.19 (t, J = 7.0 Hz, 2H), 2.04-2.06 (m, 2H), 1.62-1.70 (m,
4H), 1.52-1.54 (m, 2H), 0.93 (s, 9H), 0.21 (s, 6H).

13

C NMR (100 MHz, CDCl3): δ 202.78,

158.67, 138.66, 117.95, 114.61, 43.16, 33.40, 32.17, 26.03, 24.78, 23.59, 22.96, 22.23, 18.62, 2.82.

A procedure analogous to that used for 3.103 yielded the titled compound 3.112 (1.06 g,
76% as using 1.06 g of the acyl chloride) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.06 (q,
J = 7.1 Hz, 2H), 2.35-2.39 (m, 2H), 2.24-2.28 (m, 6H), 1.79-1.82 (m, 1H), 1.60-1.63 (m, 7H),
1.19 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 200.97, 181.43, 173.31, 106.64, 60.18,
36.45, 34.07, 30.99, 24.59, 23.71, 23.57, 22.78, 21.58, 14.17.

To a solution of the ester (0.186 g, 0.73 mmol) in 1.5 ml of methanol was added 1.5 ml of
1.1 N aqueous KOH. The resulting mixture was refluxed for three hours. After cooling down to
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r.t., the methanol was removed under reduced pressure. The resulting aqueous phase was
acidified to pH = 0, and extracted with chloroform, dried (MgSO4), filtered and concentrated to
give the product (0.138 g, 84%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 2.34-2.44 (m,
7H), 1.62-1.71 (m, 7H), 1.26-1.36 (m, 2H).

A procedure analogous to that used for 3.77 afforded an inseparable mixture of 3.115a and
3.115b (0.206 g, 92% as using 0.154 g of the SM, ratio ≈ 5:1 as indicated by 1HNMR) as
colorless oil. Major component: 1H NMR (250 MHz, CDCl3): δ 4.13 (q, J = 7.1 Hz, 2H), 2.402.45 (t, J = 6.8 Hz, 2H), 2.31-2.33 (m, 6H), 1.65-1.69 (m, 8H), 1.26 (t, J =7.1 Hz, 3H), 0.92 (s,
9H), 0.10 (s, 6H).

To a solution of dry diisopropylamine (0.12 ml, 0.85 mmol) in 0.85 ml of THF was added
n

butyllithium solution (2.5M, 0.34 ml, 0.85 mmol) slowly at -78 oC under N2 and increased the

temperature to 0 oC. After 15 minutes stirring at 0oC, the mixture was cooled to -40 oC. A
solution of the substrate 3.94 (0.249 g, 0.77 mmol) in 3.0 ml of THF was added dropwise to the
mixture, followed by the addition of TMSCl (0.11 ml, 0.85 mmol). The temperature was
increased to 0 oC and stirred for half an hour, and then partitioned between pentane and saturated
aqueous NaHCO3. The aqueous phase was extracted by pentane two more times. The organic
layer was washed with brine, dried over Na2SO4, filtered and concentrated. Flash Column (pure
hexane) afforded the product 3.117 (0.237 g, 78%) as colorless oil. 1H NMR (400 MHz, CDCl3):
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δ 2.10 (br s, 1H), 2.00 (s, 3H), 1.75-1.78 (m, 1H), 1.40-1.70 (m, 10H), 1.23-1.30 (m, 3H), 0.91
(s, 9H), 0.21 (s, 9H), 0.10(s, 6H). 13C NMR (100 MHz, CDCl3): δ 142.20, 112.16, 74.68, 47.94,
44.55, 43.82, 41.64, 28.01, 27.06, 26.12, 22.82, 20.82, 18.58, 16.93, 13.81, 1.02, -1.51, -1.87.
H

H

Me

OTBS

O
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Et3N, TMSCl
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A 15 ml of two-necked round bottom flask was charged with the ketone 3.91b (220 mg,
0.49 mmol) and anhydrous DMF (2.5 ml). Triethyl amine (0.16 ml, 1.2 mmol) was added,
followed by dropwise addition of TMSCl (0.074 ml, 0.59 mmol) under nitrogen. The solution
was then warmed to 90oC for eight hours. After cooling to r.t., the mixture was transferred to a
separatory funnel, rinsing with 5 ml of hexanes. The organic layer was washed with water (3×1
ml) and brine, dried (MgSO4), filtered and concentrated. The residue was chromatographed on
silica gel (Hex/EA = 20:1) yielded the titled compound (180 mg, 86%) as colorless oil. 1H NMR
(400 MHz, CDCl3): δ 3.54-3.56 (m, 2H), 2.39 (d, J = 17.0 Hz, 1H), 2.24 (d, J = 17.0 Hz, 1H),
2.13-2.14 (m, 1H), 1.80-1.95 (m, 2H), 1.62-1.68 (m, 2H), 1.53-1.56 (m, 3H), 1.40-1.48 (m, 4H),
1.17-1.26 (m, 1H), 1.09 (d, J = 6.8 Hz, 1H), 0..86 (s, 9H), 0.20 (s, 9H), 0.07-0.09 (m, 6H).

To a cold (0oC) stirred solution of the ketone 3.91b (310 mg, 0.68 mmol) in anhydrous
ether (6.8 ml) is added LAH solution (1.0 M in ether, 0.96 ml, 0.96 mmol) dropwise under
nitrogen. The resulting reaction mixture is increased slowly (one hour) to r.t. and stirred at r.t. for
two additional hours. The reaction is quenched by 0.05 ml of water, 0.05 ml of 15% NaOH
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solution and 0.05 ml of water in this order, dried (MgSO4), filtered and evaporated. The residue
was chromatographed on silica gel (Hex/EA = 20:1) yielded the titled compound (203 mg, 90%)
as colorless oil. 1H NMR (400 MHz, CDCl3): δ 3.98-4.04 (m, 1H), 2.42-2.47 (m, 1H), 1.94-1.95
(m, 2H), 1.70-1.76 (m, 1H), 1.52-1.68 (m, 3H), 1.44-1.50 (m, 2H), 1.30-1.34 (m, 7H), 1.11-1.20
(m, 2H), 1.00 (d, J = 7.2 Hz, 3H), 0.86 (s, 9H), 0.07 (s, 6H).

To a stirred solution of the alcohol 3.126 (0.19 g, 0.58 mmol) and Et3N (0.31 ml, 2.21
mmol) in 1.9 ml of CH2Cl2 in an ice bath under nitrogen, was added dropwise MsCl (0.09 ml,
1.16 mmol). The resulting solution was stirred for 1 hour at 0oC, sat. aqueous NH4Cl (1 ml) was
then added and the mixture was extracted with CH2Cl2 (3  2 ml). The combined organic phase
was washed with brine, dried (MgSO4) and concentrated to give the crude product, which was
purified by flash chromatography (hexanes) to yield the alkene (0.12 g, 67%) as colorless oil. 1H
NMR (400 MHz, CDCl3): δ 5.34-5.35 (m, 1H), 2.30-2.35 (m, 1H), 2.19-2.23 (m, 2H), 1.71-1.74
(m, 3H), 1.63-1.64 (m, 3H), 1.42-1.52 (m, 7H), 1.21-1.28 (m, 4H), 0.94 (t, J = 7.1 Hz, 3H), 0.88
(s, 9H), 0.08 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 136.70, 121.06, 74.00, 45.89, 44.19, 40.46,
36.67, 27.46, 25.90, 21.76, 21.37, 20.12, 19.48, 18.18, 14.56, -1.74, -1.81.

A solution of the substrate 3.78 (219 mg, 0.87 mmol) in DMSO (0.64 ml) was added
dropwise to a suspension of NaH (24 mg, 0.96 mmol, 95% purity) in DMSO (1.1 ml), and the
reaction mixture was stirred until hydrogen evolution had ceased. Then diiodomethane (0.7 ml,
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8.7 mmol) was added dropwise and the resulting mixture was warmed to 60 oC and kept stirring
for five hours. The reaction was quenched by dropwise addition of water (3.6 ml) and extracted
with 10% ether/hexane (3×5 ml). The combined organic layers were washed with brine (4 ml),
dried (MgSO4). The residue was chromatographed on silica gel (Hex/EA = 3:1 to 1:1) yielded
the titled compound (204 mg, 60%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.78-5.86
(m, 1H), 5.09-5.15 (m, 2H), 3.76 (s, 3H), 3.71 (d, J = 10.6 Hz, 1H), 3.64 (d, J = 10.6 Hz, 1H),
2.37 (s, 1H), 2.16-2.23 (m, 2H), 2.03-2.11 (m, 1H), 1.72-1.82 (m, 1H), 1.39-1.64 (m, 6H), 1.231.24 (m, 2H).

13

C NMR (100 MHz, CDCl3): δ 201.93, 169.64, 136.48, 117.26, 72.29, 62.68,

54.03, 52.42, 43.34, 42.06, 34.16, 30.55, 22.06, 19.46, 7.44.

To a stirred solution of the substrate 3.78 (0.253 g, 1.0 mmol) in 16.6 ml of
dichloromethane/ diisopropyl ethylamine (1:1) at 0oC was added dropwise MOMCl (1.5 ml, 20
mmol). After stirring two days at r.t., the reaction mixture was diluted with 20 ml of DCM and
the organic layer was washed with 20 ml of 3N HCl. The aqueous washes were back extracted
with DCM (3×20 ml), and the combined organic layers were washed with brine, dried (MgSO4),
filtered and concentrated. The residue was chromatographed on silica gel (Hex/EA = 3:1)
afforded the titled compound (0.26 g, 76%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.745.84 (m, 1H), 5.01-5.11 (m, 2H), 4.76 (d, J = 7.4 Hz, 1H), 4.71 (d, , J = 7.4 Hz, 1H), 3.71 (s, 3H),
3.48 (s, 3H), 3.37 (s, 3H), 2.95-2.96 (m, 1H), 2.81 (d, J = 18.0 Hz, 1H), 2.68 (d, J = 18.0 Hz,
1H), 2.50-2.54 (m, 1H), 2.18-2.22 (m, 1H), 1.86-1.89 (m, 1H), 1.39-1.62 (m, 7H), 1.22-1.1.28
(m, 1H).
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To a solution containing the ketone 3.78 (3.06 g, 12.1 mmol) and TBSOTf (6.1 ml, 26
mmol) in 150 ml of DCM was added dropwise triethyl amine (16.9 ml, 120 mmol). After stirring
overnight at r.t., the mixture was hydrolyzed with a saturated NaHCO3 solution. The mixture was
then extracted with DCM and the combined organic layers were dried over MgSO4, filtered and
concentrated. The residue was chromatographed on silica gel (Hex/EA = 20:1) afforded the titled
compound (5.71 g, 98%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.74-5.84 (m, 1H),
4.94-5.09 (m, 2H), 3.68 (s, 3H), 2.92 (br s, 1H), 2.50-2.56 (m, 2H), 2.35-2.43 (m, 1H), 2.08-2.24
(m, 1H), 1.70-1.72 (m, 2H), 1.47-1.56 (m, 5H), 0.97 (s, 9H), 0.87 (s, 9H), 0.20 (d, J = 5.2 Hz,
6H), 0.08 (d, J = 6.8 Hz, 6H).

To a stirred cold solution of the substrate 3.144 (5.33 g, 11.1 mmol) in 28 ml of dry ether
was added LAH solution (1.0 M in ether, 10.8 ml, 10.8 mmol) dropwise under nitrogen. The
reaction mixture was stirred for 1.5 hours at 0oC, diluted with ether (28 ml), and quenched by
dropwise addition of water (2.8 ml). The ice-water bath is removed, and the resulting gray
suspension is allowed to reach r.t. and the mixture is stirred vigorously for an additional one
hour. Then the mixture was diluted with 50 ml of ether. Anhydrous Na2SO4 (20 g) was added,
the suspension is stirred for 30 minutes, and filtered. The filter cake is washed twice with ether.
The solvent is removed under reduced pressure and the residue is purified by column (Hex/EA =
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5:1) afforded the titled compound (2.73 g, 73%) as crystalline solid. 1H NMR (400 MHz,
CDCl3): δ 5.72-5.82 (m, 1H), 5.04-5.09 (m, 2H), 3.97-4.03 (m, 1H), 3.45-3.51 (m, 1H), 2.712.80 (m, 1H), 2.65-2.69 (m, 2H), 2.51-2.57 (m, 2H), 2.29 (br s, 1H), 2.10-2.20 (m, 1H), 1.901.93 (m, 1H), 1.72-1.79 (m, 1H), 1.52-1.56 (m, 3H), 1.27-1.31 (m, 1H), 1.11-1.14 (m, 1H), 0.86
(s, 9H), 0.089 (d, J = 5.4 Hz, 6H).

13

C NMR (100 MHz, CDCl3): δ 214.02, 137.29, 116.19,

75.29, 61.78, 57.19, 55.75, 48.90, 35.23, 34.60, 30.02, 25.62, 19.62, 19.47, 17.97, -1.98.

A procedure analogous to that used for 3.89 afforded the diol 3.151 (1.18 g, 45% as using
2.48 g of the SM) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.00 (dd, J1 = 8.1 Hz and J2 =
11.3 Hz, 1H), 3.63-3.67 (m, 2H), 3.48 (dd, J1 = 4.3 Hz and J2 = 11.3 Hz, 1H), 2.64 (d, J =15.4
Hz, 1H), 2.50-2.54 (m, 2H), 2.29 (s, 1H), 1.81-1.88 (m, 3H), 1.67-1.76 (m, 3H), 1.46-1.55 (m,
7H), 0.84 (s, 9H), 0.071 (d, J = 3.8 Hz, 6H).

13

C NMR (100 MHz, CDCl3): δ 214.05, 75.78,

63.12, 61.81, 57.30, 55.86, 49.49, 36.05, 34.76, 31.33, 25.76, 21.63, 20.03, 19.58, 18.10, -1.83.

At 0oC, triethyl amine (1.85 ml, 13.2 mmol) was added to a solution of the diol 3.151
(0.788 g, 2.2 mmol) in 28 ml of dry DCM followed by dropwise addition of MsCl (0.69 ml, 8.8
mmol). The reaction mixture was slowly allowed to warm to r.t. in half an hour and then stirred
at r.t. for 10 minutes. Sat. aqueous NH4Cl solution (4.5 ml) was then added, and the mixture was
then separated. The aqueous phase was extracted by DCM (2×10 ml) and the combined organic
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phase was dried over MgSO4, filtered and concentrated to give the dimesylate along with some
inorganic salts.
DBU (0.7 ml, 4.7 mmol) was added to a solution of the dimesylate in 11 ml of THF at r.t.
(yellow ppt. formed immediately). After being stirred at r.t. for 3 hours, the mixture was diluted
with 50 ml of ethyl acetate and washed with 10 ml of 1N HCl and brine, dried over MgSO4,
filtered and concentrated. Flash column chromatography on silica gel (Hex/EA = 3:1) of the
residue afforded the product (0.82 g, 89%) as colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.91
(s, 1H), 5.20 (s, 1H), 4.20-4.23 (m, 2H), 2.98 (s, 3H), 2.78-2.84 (m, 1H), 2.48-2.52 (m, 1H),
1.80-2.00 (m, 3H), 1.58-1.78 (m, 7H), 1.20-1.24 (m, 3H), 0.83 (s, 9H), 0.07 (s, 9H). 13C NMR
(100 MHz, CDCl3): δ 199.70, 148.61, 121.16, 74.50, 69.95, 56.34, 46.89, 40.39, 37.38, 34.89,
27.92, 26.34, 25.77, 21.90, 19.32, 18.09, -1.84.

Sodium iodide (0.589 g, 3.9 mmol) was added to a solution of the mesylate (82 mg, 0.2
mmol) in 10 ml of acetone at r.t., and the resulting mixture was heated to reflux for 3 hours. The
solution was cooled down to r.t. and the acetone was removed under vacuum. The residue was
taken up in ether and water. The ethereal portion was washed with sat. sodium bisulfate solution
and brine, dried (MgSO4), filtered and concentrated to afford the crude product, which was
purified by flash column on silica gel (Hex/EA = 20:1) to give the iodide (71 mg, 80%) as white
crystalline solid. 1H NMR (400 MHz, CDCl3): δ 5.91 (s, 1H), 5.19 (s, 1H), 3.18-3.21 (m, 2H),
2.79 (d, J = 17.9 Hz, 1H), 2.47-2.54 (m, 1H), 1.80-1.95 (m, 2H), 1.73-1.78 (m, 4H), 1.45-1.60
(m, 4H), 1.18-1.22 (m, 4H), 0.84 (s, 9H), 0.08 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 199.81,
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148.73, 121.04, 74.48, 56.39, 46.45, 40.52, 34.90, 32.19, 26.99, 26.43, 25.87, 19.39, 18.12, 7.05,
-1.76.

To a cold (-78oC) stirred solution of the substrate (3.09 g, 6.8 mmol) in 34 ml of dry THF
was added a solution of NBS (1.451 g, 8.2 mmol) in 34 ml of dry THF under nitrogen, and the
resulting mixture was stirred at -78oC for three hours. The mixture was then warmed to r.t. and
poured into a separatory funnel containing ether. The mixture was washed with sat. NaHCO3
solution and brine, dried (MgSO4) and filtered to afford the bromide 3.158.
DBU (1.6 ml, 10.7 mmol) was added to a solution of the bromide in 50 ml of benzene at
r.t. (yellow ppt. formed immediately). After being stirred at r.t. for one hour, saturated aqueous
NH4Cl solution was added and the mixture was extracted with ether. The combined organic
extracts were washed with brine, dried over Na2SO4, filtered and concentrated. Flash column
chromatography on silica gel (Hex/EA = 3:1) of the residue afforded the product (1.0 g, 44%) as
colorless oil. 1H NMR (400 MHz, CDCl3): δ 5.93-6.04 (m, 1H), 5.21-5.37 (m, 1H), 3.63-3.71
(m, 2H), 2.80-2.96 (m, 1H), 2.50-2.59 (m, 1H), 1.88-1.93 (m, 1H), 1.53-1.67 (m, 9H), 1.24-1.27
(m, 3H), 0.86-0.92 (m, 9H), 0.09-0.20 (m, 6H).
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A procedure analogous to that used for 3.91 afforded the iodide 3.153 (1.3 g, 100% as
using 1.0 g of the SM) as pale yellow oil.

To the freshly prepared solution of LDA (1.86 mmol) in 1.8 ml of dry THF was added a
solution of the substrate (0.3 g, 0.93mmol) in 1.0 ml of dry THF dropwise at -78oC under
nitrogen. After 15 minutes stirring at -78oC, a solution of the PhSeI [this is made by adding
iodine (1.63 g, 6.4 mmol) to a solution of Ph2Se2 (2.0 g, 6.4 mmol) in 5.0 ml of THF, stirring at
r.t. for 15 minutes] was introduced and the resulting reaction mixture was warmed to r.t. and
stirred overnight. Saturated aqueous NH4Cl was added, and the mixture was extracted with ether.
The combined organic extracts were dried (MgSO4), filtered and concentrated to leave a residue
which was purified by column chromatograph on silica gel (pure hexanes to Hex/EA = 40:1 ) to
give a mixture of the selenide 3.160 and the unreactive starting material 3.94 (ratio ≈ 1:1), which
was recycled in the same reaction again.
To a cold (0oC) stirred solution of the selenide in 10 ml of chloroform was added mCPBA (0.428 g, 1.9 mmol). The reaction mixture was stirred at 0oC for 15 minutes and then
treated with diisopropyl ethyl amine (0.5 ml, 2.9 mmol) and increased to r.t. After 20 minutes,
the mixture was diluted with 20 ml of ether. The organic layer was washed with a saturated
aqueous solution of Na2S2O3 (10 ml), saturated aqueous solution of NaHCO3 (10 ml), dried over
MgSO4, filtered and concentrated. The crude residue was chromatographed on silica gel
(Hex/EA = 40:1) yielded the enone 3.159 (0.175 g, two steps yield: 58%) as colorless oil. 1H
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NMR (400 MHz, CDCl3): δ 5.93 (s, 1H), 5.14 (s, 1H), 2.89 (s, 1H), 2.52 (s, 1H), 2.27-2.39 (m,
2H), 1.43-1.82 (m, 9H), 1.25-1.32 (m, 3H), 0.91 (s, 9H), 0.11 (d, J = 5.5 Hz, 6H). 13C NMR (100
MHz, CDCl3): δ 204.96, 149.89, 118.66, 74.74, 57.08, 44.06, 43.97, 41.38, 36.44, 26.96, 26.65,
26.13, 19.87, 18.67, 17.18, -1.53, -1.75.
An alternative way to prepare the enone 3.159 is to leave the selenide 3.160 without any
solvent at r.t. for two days, after which a flash column is applied to purify the product. A similar
yield of 3.159 was identified.

To a cold (-78oC) stirred solution of the substrate (0.21 g, 0.53 mmol) in 3 ml of dry THF
was added a solution of NBS (0.47 g, 2.7 mmol) in 5 ml of dry THF under nitrogen, and the
resulting mixture was stirred at -78oC for one hour. The mixture was then warmed to r.t. and
poured into a separatory funnel containing ether. The mixture was washed with sat. NaHCO3
solution and brine, dried (MgSO4), filtered and concentrated. The crude residue was
chromatographed on silica gel (Hex/EA = 40:1) yielded the bromide 3.161 (0.21 g, 98%). 1H
NMR (400 MHz, CDCl3): δ 2.66-2.67 (m, 1H), 2.52-2.54 (m, 1H), 2.30-2.47 (m, 3H), 2.00-2.06
(m, 4H), 1.72-1.99 (m, 5H), 1.51-1.56 (m, 2H), 1.24-1.33 (m, 2H), 0.91 (s, 9H), 0.12 (d, J = 9.7
Hz, 6H). 13C NMR (100 MHz, CDCl3): δ 211.43, 75.05, 58.68, 55.97, 49.08, 43.20, 41.16, 31.60,
29.06, 27.28, 26.02, 23.61, 19.33, 18.58, 15.19, -1.58, -1.77.
DBU (0.41 ml, 2.7 mmol) was added to a solution of the bromide (0.21 g, 0.52 mmol) in
5.5 ml of benzene at r.t. and the resulting mixture was heated to reflux for 18 hours. After cooled
down to r.t., saturated aqueous NH4Cl solution was added and the mixture was extracted with
ether. The combined organic extracts were washed with brine, dried over Na2SO4, filtered and
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concentrated. Flash column chromatography on silica gel (Hex/EA = 40:1) of the residue
afforded the product (0.16 g, 98%) as colorless oil.

To a dry flask was added CeCl3·7H2O (3.67 g, 9.86 mmol) and a stir bar. The flask was
placed under high vacuum and temperature was raised to 120-140 oC for one hour and then at
140-160 oC for two hours. The flask was then allowed to cool to r.t. and 18 ml of dry THF was
added. After being mixed for 30 minutes, the slurry was cooled to -78 oC and MeLi solution (1.6
M, 5.5 ml, 8.80 mmol) was added dropwise and with vigorous stirring. After stirring for 15
minutes at -78 oC, the brown slurry was warmed to 0 oC and the ketone 3.94 (0.64 g, 1.97 mmol)
in 7 ml of dry THF was added dropwise. The reaction was stirred at 0 oC for two hours. The
workup was effected by adding TMEDA (1.5 ml, 9.86 mmol) and allowing the mixture to stir for
15 minutes. The solution was poured into saturated aqueous NaHCO3 and DCM. The organic
layer was separated and the aqueous layer was extracted by DCM three times. The combined
organic layers were dried over Na2SO4, filtered and concentrated in vacuo. Flash column
chromatography on silica gel (Hex/EA = 20:1) of the residue afforded the product (0.64 g, 95%)
as colorless oil. 1H NMR (400 MHz, CDCl3): δ 2.44-2.49 (m, 1H), 2.18-2.32 (m, 2H), 2.00-2.04
(m, 1H), 1.81-1.84 (m, 2H), 1.66-1.74 (m, 2H), 1.54-1.57 (m, 2H), 1.38-1.45 (m, 5H), 1.26-1.28
(m, 5H), 1.07 (s, 1H), 0.96 (d, J = 7.2 Hz, 3H), 0.91 (s, 9H), 0.11 (d, J = 5.4 Hz, 6H). 13C NMR
(100 MHz, CDCl3): δ 76.07, 74.90, 52.72, 45.42, 44.05, 41.04, 39.66, 30.81, 27.85, 26.58, 26.27,
23.66, 20.00, 18.92, 12.03, -1.32, -1.61.
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The alcohol 3.163 (0.64 g, 1.87 mmol) in 6 ml of dry benzene was added dropwise to a
solution of Burgess reagent (0.63 g, 2.64 mmol) in 4 ml of dry benzene at r.t. under nitrogen.
After the addition was complete, the temperature was raised to 50oC and maintained for one hour.
After cooled down to r.t., water (4 ml) was added and the benzene layer was separated. The
water layer was extracted with ether twice and the ether phase was combined with benzene, dried
over MgSO4, filtered and concentrated in vacuo. Flash column chromatography on silica gel
(pure hexane) of the residue afforded the product (0.53 g, 87%) as colorless oil. 1H NMR (400
MHz, CDCl3): δ 4.67 (s, 1H), 4.60 (s, 1H), 2.85-2.87 (m, 1H), 2.27-2.45 (m, 3H), 1.68-1.89 (m,
7H), 1.34-1.55 (m, 3H), 1.22- 1.28 (m, 3H), 1.10 (d, J = 6.6 Hz, 3H), 0.92 (s, 9H), 0.12 (s, 6H).
13

C NMR (100 MHz, CDCl3): δ 159.00, 106.16, 75.08, 51.82, 44.88, 44.51, 42.26, 35.64, 31.60,

29.86, 28.90, 26.20, 21.51, 19.62, 16.20, 14.12, -1.50, -1.61.
3.10.3 Spectral Data
Spectral data are shown from the next page.
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Figure 3.4 1H NMR (400 MHz, CDCl3) of Compound 3.74
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Figure 3.5 1H NMR (400 MHz, CDCl3) of Compound 3.77
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Figure 3.6 1H NMR (400 MHz, CDCl3) of Compound 3.81
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Figure 3.7 1H NMR (400 MHz, CDCl3) of Compound 3.82
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Figure 3.8 1H NMR (250 MHz, CDCl3) of Compound 3.83
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Figure 3.9 1H NMR (400 MHz, CDCl3) of Disilyl Ether
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Figure 3.10 13C NMR (100 MHz, CDCl3) of Disilyl Ether
178

OH

Me

H
OTBS

TBSO
3.86

Figure 3.11 1H NMR (400 MHz, CDCl3) of Compound 3.86
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Figure 3.12 13C NMR (100 MHz, CDCl3) of Compound 3.86
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Figure 3.13 1H NMR (400 MHz, CDCl3) of Compound 3.87
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Figure 3.14 13C NMR (100 MHz, CDCl3) of Compound 3.87
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Figure 3.15 1H NMR (400 MHz, CDCl3) of Compound 3.88
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Figure 3.16 1H NMR (400 MHz, CDCl3) of Compound 3.89
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Figure 3.17 13C NMR (100 MHz, CDCl3) of Compound 3.89
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Figure 3.18 1H NMR (400 MHz, CDCl3) of Compound 3.91
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Figure 3.19 13C NMR (100 MHz, CDCl3) of Compound 3.91
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Figure 3.20 1H NMR (400 MHz, CDCl3) of Compound 3.91b
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Figure 3.21 13C NMR (100 MHz, CDCl3) of Compound 3.91b
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Figure 3.22 1H NMR (400 MHz, CDCl3) of Compound 3.93
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Figure 3.23 13C NMR (100 MHz, CDCl3) of Compound 3.93
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Figure 3.24 1H NMR (400 MHz, CDCl3) of Compound 3.94
192

H
H
OTBS

Me
O
3.94

Figure 3.25 13C NMR (100 MHz, CDCl3) of Compound 3.94
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Figure 3.26 1H NMR (400 MHz, CDCl3) of Compound 3.95
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Figure 3.27 13C NMR (100 MHz, CDCl3) of Compound 3.95
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Figure 3.28 1H NMR (400 MHz, CDCl3) of Compound 3.98
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Figure 3.29 13C NMR (100 MHz, CDCl3) of Compound 3.98
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Figure 3.30 1H NMR (400 MHz, CDCl3) of Compound 3.103
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Figure 3.31 13C NMR (100 MHz, CDCl3) of Compound 3.103
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Figure 3.32 1H NMR (400 MHz, CDCl3) of Compound 3.104
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Figure 3.33 1H NMR (400 MHz, CDCl3) of Compound 3.112
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Figure 3.34 1H NMR (400 MHz, CDCl3) of Compound 3.115
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Figure 3.35 1H NMR (400 MHz, CDCl3) of Compound 3.117
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Figure 3.36 13C NMR (100 MHz, CDCl3) of Compound 3.117
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Figure 3.37 1H NMR (400 MHz, CDCl3) of Compound 3.119
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Figure 3.38 1H NMR (400 MHz, CDCl3) of Compound 3.126
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Figure 3.39 1H NMR (400 MHz, CDCl3) of Compound 3.127
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Figure 3.40 13C NMR (100 MHz, CDCl3) of Compound 3.127
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Figure 3.41 1H NMR (400 MHz, CDCl3) of Compound 3.138
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Figure 3.42 13C NMR (100 MHz, CDCl3) of Compound 3.138
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Figure 3.43 1H NMR (400 MHz, CDCl3) of Compound 3.144
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Figure 3.44 1H NMR (400 MHz, CDCl3) of Compound 3.146
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Figure 3.45 13C NMR (100 MHz, CDCl3) of Compound 3.146
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Figure 3.46 1H NMR (400 MHz, CDCl3) of Compound 3.149
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Figure 3.47 1H NMR (400 MHz, CDCl3) of Compound 3.151
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Figure 3.48 1H NMR (400 MHz, CDCl3) of Compound 3.153
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Figure 3.49 13C NMR (100 MHz, CDCl3) of Compound 3.153
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Figure 3.50 1H NMR (400 MHz, CDCl3) of Compound 3.154
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Figure 3.51 13C NMR (100 MHz, CDCl3) of Compound 3.154
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Figure 3.52 1H NMR (400 MHz, CDCl3) of Compound 3.157
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Figure 3.53 13C NMR (100 MHz, CDCl3) of Compound 3.157
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Figure 3.54 1H NMR (400 MHz, CDCl3) of Compound 3.159
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Figure 3.55 13C NMR (100 MHz, CDCl3) of Compound 3.159
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Figure 3.56 1H NMR (400 MHz, CDCl3) of Compound 3.161
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Figure 3.57 13C NMR (100 MHz, CDCl3) of Compound 3.161
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Figure 3.58 1H NMR (400 MHz, CDCl3) of Compound 3.163
226

Figure 3.59 13C NMR (100 MHz, CDCl3) of Compound 3.163
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Figure 3.60 1H NMR (400 MHz, CDCl3) of Compound 3.164
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Figure 3.61 13C NMR (100 MHz, CDCl3) of Compound 3.164
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